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ABSTRACT 
Neuronal development is an investigation that has yet to be fully understood. Different 
transcription factors and markers are expressed differently throughout the developmental cascade 
of a neuron, either in the form of presence/absence of environmental signals. In this study, a 
Boolean modeling framework was employed to develop a model of the early stages of the 
neurodevelopmental cascade starting with embryonic stem cell proliferation and differentiation. 
A Boolean model was useful in terms of synthesizing previous work and simplifying the 
neurodevelopmental cascade using in silico analysis. In this module, I looked at the proliferative 
and differentiative qualities of an embryonic stem cell in relation to the Leukemia Inhibitory 
Factor (LIF), Bone Morphogenetic Protein (BMP), 2i (serum containing LIF) and growth factor 
(GF) environments. Drawing on the extensive experimental literature on embryonic stem cell 
maintenance, I assembled a model that represents a naive embryonic stem cell, and the coupling 
between this system and the cell cycle and pluripotency network. Using Boolean sampling, live 
attractor states were acquired and box graphs and time course experiments were assembled to 
represent different molecular and phenotype changes that occur in different combinations of 
environmental stimuli. Unique, unexpected phenotypic transitions based on single environment 
manipulation were analyzed and studied, pointing out flaws in the model and postulating gaps in 
knowledge in current biology. The current model possibly may require the addition of other 
pathways to supplement and improve the results in terms of providing a further understanding of 
the present phenotypic transitions as well as providing a wider variety of phenotypes that can be 
modeled. 
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INTRODUCTION 
Stem cell biology  
 Stem cells are one of the greatest discoveries of modern science and medicine. These 
cells have an incredible power, as they are able to serve as a tool to unearth a plethora of cures in 
medicine, but they also provide deeper insight to our development and adult function on the 
cellular level. There are three major stem cell types defined as embryonic stem cells, adult stem 
cells, and induced pluripotent stem cells. Embryonic stem cells originate in and make up the 
blastocyst, a small structure that plays a crucial role in development, where these cells are 
maintained in a fully pluripotent, undifferentiated state. These cells provide insight as to how we 
humans develop, as well as to how embryos differentiate into different cell types to make 
complete adult organisms. These cells are totipotent, meaning that they can become any type of 
cell our adult bodies contain. The potential of embryonic stem cells is second to none, as they 
give rise to the possibility that we can generate specialized cells on demand, to fix and/or replace 
damaged tissues and restore health (Vazin et al., 2010).  
In contrast, adult stem cells are multipotent, but tissue-specific stem cells. This means 
that each adult stem cell type can only develop into a select subset of adult cells, specifically in 
their tissues of origin. For example, an adult stem cell in the brain cannot differentiate into 
cardiovascular tissue and vice versa. Stem cells have been found to be relevant to a variety of 
fundamental and dynamic processes in the brain (Gage, 2000).  In the field of medical research, 
the usage of these stem cells could provide researchers new insights on how to treat and cure 
physical damage and other types of disease, such as diabetes (Maehr et al, 2009). These cells are 
not only crucial to our development, but their potential and power is necessary to reign in to 
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further develop advances in medicine for the overall quality of life for our species, and to learn 
more about ourselves.  
 
The development and biology of neural stem cells  
 In the development of mammalian species, a zygote is formed at conception. This zygote 
evolves into a blastocyst. A repeated round of divisions then gives rise to totipotent cells capable 
of giving rise to a fully complete, normally functioning organism when it is implanted into a 
female host (uterus; Figure 1) (Gage, 2000). From there, the structure develops into a blastocyst, 
in which an outer trophoblast cell layer surrounds the embryonic stem cells (inner cell mass). A 
layer of these cells then gives rise to the ectoderm (Figure 1, pink), and subsequently the rest of 
the neural system lineage. These cells are still capable of giving rise to a healthy organism, 
except that they no longer receive the same morphogens from the female host as totipotent cells 
and thus no longer become trophoblasts (Gage, 2000).  
Figure 1. Early embryonic differentiation in space and time. Pink: ectoderm.(Zephyris. (2010). The first few 
weeks of embryogenesis in humans. Beginning at the fertilised egg, ending with the closing of the neural tube. 
Retrieved from https://commons.wikimedia.org/wiki/File:HumanEmbryogenesis.svg) 
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During development, three distinct layers arise in the blastocyst: the endoderm (Figure 1, 
maroon), the mesoderm (arising between the ectoderm and endoderm around day 12, not shown), 
and the ectoderm (Figure 1, pink). 
Each specific layer differentiates into 
different cell types. The mesoderm 
typically differentiates into bone and 
cartilage, and the ectoderm 
differentiates into the brain and 
neural tissue (Vazin et. al., 2010).  
Multipotent ectodermal cells 
later differentiate into neural 
progenitors. These cells then 
undergo a process that makes them 
committed neural progenitors, 
namely neuronal or glial progenitors. 
These cells proliferate little, and they 
are not functional in the brain. As 
they divide, they differentiate into 
completely differentiated, non-
mitotic neurons or glia. In order to 
fully comprehend the origin and 
capabilities of each developmental 
stage of neurogenesis, it is important 
Figure 2. Hierarchy of stem cell stages leading to mature 
neurons. From [Gage, F. H. (2000). Mammalian Neural Stem 
Cells. Science, 287(5457), 1433]. Reprinted with permission 
from AAAS. (Gage, 2000) 	
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to be cognizant of the precise cell type cascade that leads to an adult neuron. Figure 2 shows 
each stage of the cascade, including the source and restrictions of neural capacity of each cellular 
stage.  
In the early stages of neurogenesis, the central nervous system (CNS) arises from 
ectoderm of the neural plate (Herrup et. al., 2007). As the CNS completes its development and 
neurogenesis is finalized, all CNS neurons become postmitotic (Herrup et. al., 2007), meaning 
that they will no longer go through the cell cycle to further proliferate and differentiate. Beyond 
the neural tube, neural progenitors specific to each sub-region of the brain (Figure 3, teal) loose 
most of their renewal potential. Nevertheless, they can further differentiate into specific types of 
neurons at each location (Figure 3, green).  
 
Figure 3. Tissue-specific differentiation of neuronal cells during neurogenesis.  
 
The nervous system is unique because it does not require the rate of regeneration that is 
demanded by other functional systems in our body (Gage, 2000). However, recent discoveries 
have refined this assessment. Studies have found that neural stem cells exist in both development 
and adult brains of humans (Gage, 2000). Although neural stem cells have been discovered in 
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both stages, there is no one definite region where stem cells originate in the brain. The available 
locations, however, dramatically decrease in adulthood (Gage, 2000). Specifically, adult neural 
stem cells have been generally localized on the ventricular zone (VZ) and the subventricular 
zone (SVZ), which line the lateral ventricle and the denate gyrus by the hippocampus. During 
development, the subventricular zone develops after ventricular zone, which are both locations of 
final cell division (Herrup et. al., 2007). Interestingly enough, in the adult brain, the ventricular 
zone contains no mitotic cells, whereas subventricular zone does (Herrup et. al., 2007).  
Even though there are a large number of neuronal types, neuroscientists developing 
experimental models of differentiation often only refer to generic neurons as the final products or 
steps in the neurogenesis cascade. Exactly how the differentiation cascade from ectoderm to 
distinct types of mature neurons unfolds is still not well understood. In this study, we focus on 
the first cell type-change along the differentiation path from embryonic stem cells to the neurons 
of the central nervous system (CNS); namely, the embryonic stem cell (ESC) → ectoderm 
transition. Our goal is to understand the molecular mechanisms that a) turn on the ectodermal 
lineage-specific transcriptional program, b) turn off the embryonic stem cell maintenance 
program and c) drive the cell cycle in different cell lineages. 
 
Molecular mechanisms of neuronal proliferation and differentiation  
There have been multiple studies on the proliferation and differentiation of neural stem 
cells. Most of these studies have focused on cell-to-cell signaling, cell polarity, and cell division 
symmetry (Farkas et al., 2008). Recently, there have been a few studies that investigate these 
focuses through the use of grafts. In grafts, neural stem cells differentiate based on the local 
environment rather than their inherent properties (Gage, 2000). These studies have shown that 
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differentiation is based on the local environment, which results in chimerism (Gage, 2000). In 
addition, scientists discovered that in the developing brain, neural stem cells tend to move to 
areas of damage and ultimately fix and/or replace damaged cells (Gage, 2000). In the adult brain 
neural stem cells placed into regions of damage can retain and perform the properties of normal 
adult neural stem cells. Interestingly, these studies also revealed that neural stem cells have 
different functions when implanted in different regions of the adult brain. For example, when the 
neural stem cells were implanted in the rostral migratory stream, they differentiated into 
olfactory bulb neurons (Gage, 2000). In contrast, when neural stem cells are implanted in regions 
of the brain that do not generate new neurons, the neural stem cells differentiate into glia (Gage, 
2000). 
In the adult brain, there are several characteristics of neural stem cells that help determine 
whether they should proliferate. There have been two areas of the adult brain that are specifically 
characterized by high levels of cell proliferation; the subventricular zone (SVZ) and the 
subgranular zone (SGZ) of the denate gyrus of the hippocampus (Gage, 2000). Further studies 
found other areas of proliferation as well. It was also discovered that a subpopulation of 
ependymal cells in lining of 3rd ventricle were stem cells (Gage, 2000). Intriguingly, these cells 
were shown to proliferate and differentiate into either neural or glial cells, depending on the 
symmetry or asymmetry of their division. One type of environmental signal leading to increased 
neural stem cell proliferation is the presence of glucocorticoids. Furthermore, the glutamatergic 
receptor antagonist MK-801 also increases proliferation (Gage, 2000). Finally, seizures in the 
temporal lobe have been found to increase proliferation & neurogenesis in denate gyrus (Gage, 
2000). 
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In parallel with the response of other somatic cell types, the presence of certain growth 
factors has also proven to increase proliferation. For example, the growth factor EGF increased 
proliferation in SVZ, but not the SGZ (Gage, 2000). Interestingly, EGF also influenced neuronal 
cell fate in SVZ, as it lead to the production of more glia than neurons (Gage, 2000). Another 
growth factor, FGF-2, increased the number of neurons instead. The mechanism by which FGF-2 
preferentially leads to neuronal production is still not known. Lastly, the presence of the brain-
derived neurotrophic factor can also increase the number of neural stem cells that proliferated 
into neurons (Gage, 2000). Interestingly, if a factor increases the production of neurons, it will 
likely increase the size of the olfactory bulbs. As a result, olfactory bulb size can be used as a 
convenient readout for testing the effects of these factors on neuron production.  
In addition to the signal – proliferation responses described above, the molecular 
pathways that control neural stem cells behavior have also been extensively studied (Poser et al., 
2015). The STAT3, or signal transducer and activator of transcription 3 pathway, for example, is 
crucial for neural stem cell (NSC) function. The phosphorylation of STAT3 is essential for NSC 
survival (Poser et al. 2015). The activation and phosphorylation of STAT3 is caused by a 
plethora other factors that serve as a convergence point for STAT3 phosphorylation and Hes3 
activation (Poser et al., 2015). Some of these factors are FGF, the Noncanonical Notch signaling 
branch, and the angiopoietin2/Tie2 system (Poser et al., 2015). These pathways are often blocked 
by the JAK pathway, which promotes the survival of pluripotent stem cells (PSCs) instead of 
NSCs (Poser et al., 2015).  
In addition to neural progenitor cell function, both Stat 3 and Hes3 have been implicated 
in brain cancer. For example, hairy and enhancer on split 3 (Hes3), is known to regulate 
glioblastoma multiform cancer stem cells and adrenomedullary chromaffin regulators (Poser et 
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al., 2015). STAT3 mediates carcinogenesis in models of prostate cancer, which in turn is useful 
to study and treat similar cancer types (Poser et al., 2015). Lastly, Hes3 has been shown to turn 
non-neural stem cells into NSCs (Poser et al., 2015).  
 
Molecular mechanisms of embryonic stem cell maintenance  
Transcription factors play a crucial role in embryonic stem cells as well as at each 
subsequent stage of differentiation. These transcription factors also play a role in whether a cell 
decides to proliferate or not. The three main transcription factors required for embryonic stem 
cell maintenance are Oct4, Sox2, and Nanog (Figure 4). All three of these transcription factors 
play a role in cell self-renewal, proliferation and differentiation, as they all work together by 
forming a feedback loop (Amini, 2014).   
 
Figure 4. Pluripotency core circuit composed of Oct4, Sox2, and Nanog. All three transcription factors regulate 
one another, and they all have the ability to self-sustain. 
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The function of Oct4 is to regulate the expression of target genes that maintain ESC cell 
functions, and blocks lineage-specific transcription factors. It helps coordinate many cellular 
functions and it plays a big role in cell fate (Radzisheuskaya, 2013). It is also important in self-
renewal, pluripotency and cell differentiation (Quinlan, 2011). Oct4 works together with Sox2 by 
forming a heterodimer. The function of Sox2 is to help activate target genes. Cells low in Sox2 
tend to lose their pluripotency and differentiate rather quickly (Quinlan, 2011). The Oct4 / Sox2 
complex also positively regulates Nanog expression (van den Berg et al, 2008), both directly and 
through Esrrb activation (Esrrb is a direct activator of Nanog) (Zhang et al., 2008). Lastly, the 
function of Nanog is to determine cell fate, as well as to maintain pluripotency and prevent 
differentiation (Chickarmane et al. 2012). Nanog overexpression is a key factor in driving 
embryonic cell proliferation (Hanna et al. 2009). In embryonic stem cells, the precise activity 
level of these three factors can determine what a cell differentiates into, or if the cell will stay in 
its undifferentiated state (Chickarmane et al. 2012). Finally, Nanog can also trigger apoptosis 
(Zernicka-Goetz et al., 2009).  
It has also been discovered that overexpressing certain transcription factors can 
reprogram a somatic cell back to its pluripotent state (Hanna et al., 2009). It is clearly 
demonstrated that these three transcription factors play a crucial role in these cells. It has been 
discovered that inducing pluripotency is also possible using the Yamanaka factors Oct4, Sox2, c-
Myc and Klf4 under embryonic stem cell culture conditions (Takahashi & Yamanaka, 2006). 
Interestingly, it has been further discovered that these induced pluripotent state (iPS) cells can be 
done solely using Oct4, Sox2, and Klf4. (Takahashi & Yamanaka, 2006) 
In addition to these transcription factors, there are a series of signaling pathways and their 
target transcription factors that play a role in stem cell behavior. Primarily, previous literature 
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focuses on the STAT3, Lin28, LIF (Leukemia Inhibitory Factor), and CDX2 factors and the 
p53/p21, and Wnt pathways (Rosso & Inestrosa, 2013). In our study, we primarily focus on the 
LIF pathway, which is a direct activator of the Oct4 / Sox2 / Nanog network, and which is 
crucial to embryonic stem cell pluripotency (Niwa et al., 2009) and self-renewal (Dunn et al., 
2014).  
 
The Leukemia Inhibitory Factor (LIF) environment 
Leukemia inhibitory factor, also knows as LIF, is an environmental stimulus that affects a 
cell by maintaining pluripotency (Figure 5). LIF also acts as a driver of the cell cycle, as it not 
only promotes cell growth by activating the PI3K / AKT pathway, but it also promotes cell cycle 
entry by activating Myc and Cyclin D via the STAT3 pathway, leading to Klf4 (LIF → STAT3 
→ Klf4 → Myc → Cyclin D).  
 When an ESC is exposed to LIF, it maintains its pluripotent qualities as well as ability to 
proliferate. While this specific environment is not easily studied in vivo, ESC can be placed in an 
environment containing LIF in vitro. These studies employ serum containing LIF-2i , where 2i is 
a double inhibitor cocktail that blocks MEK (MAPK/ERK kinase; one of the kinases in the 
MAPK cascade), as well as GSK3 (Glycogen synthase kinase 3; an AKT inhibitor) activity. This 
2i inhibitor helps block ERK from inhibiting a key activator of Nanog, Tbx3, while maintaining 
AKT signaling. The net result is a stabilization of the embryonic stem cell state (Fig. 5).  
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Figure 5. Pluripotency circuit in the presence of environmental stimuli. Orange: input signals; blue: regulatory 
molecules involved in pluripotency. 
 
The Bone Morphogenetic Protein (BMP) environment  
 Bone morphogenetic protein (BMP) is 
an environmental morphogen that has an ever-
changing role along the neuronal development 
cascade. After gastrulation, the ectoderm layer 
forms a thickened plate, and produces BMP in 
the areas on the edges, where the non-neural 
ectoderm develops. In contrast, the presence of 
Noggin towards the middle blocks BMP 
signaling and gives rise to neural ectoderm 
(Figure 6, top; see Figure 5 for BMP signaling). 
The neuroectoderm then invaginates, forming 
the neural tube but also bringing the BMP- Figure 6. Formation of the neural tube , then the neural crest, driven by BMP gradients. Blue: 
ectoderm; purple: neuroectoderm; green: neural 
fold & neural crest.  
BMPBMP
BMP
no BMP
Noggin
no BMP signal
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producing epidermis in close proximity to the dorsal (top) side of the tube. The BMP released by 
these cells helps the cells in the top of the neural tube differentiate into neural crest cells. The 
remaining cells of the neural tube, exposed to intermediate to low levels of BMP, form the 
central nervous system (CNS). 
 
Experimental investigations of neural stem cell specification 
Neural stem cells (NSC) have been previously studied both in vitro and in vivo. 
Commonly, in vitro studies are divided into two stages. The first stage is obtaining the cells 
before they are forced to proliferate, and the second stage is studying the cells after they have 
proliferated. Neural stem cells are acquired by dissecting out a region of a fetal or adult brain that 
was shown to contain dividing cells (Gage, 2000). In the fetal brain, they can be obtained from 
nearly anywhere in the brain, whereas in the adult brain they are obtained from the 
subventricular zone (SVZ) and hippocampus (Gage, 2000). Once the neural stem cells have been 
separated from other neural tissue, they are exposed to high concentrations of growth factors in 
order to induce proliferation. The most commonly used mitogen is fibroblast growth factor–2 
(FGF-2) and epidermal growth factor (EGF) (Gage, 2000). After the neural stem cells have gone 
through proliferation, mitogens are removed and the cells are induced to differentiate (Gage, 
2000). This is accomplished by exposing them to other factors (such as FGF or Wnt) that induce 
specificity of their differentiation into neurons.  
During in vivo studies, neural stem cells are detected via by using either thymidine uptake 
or bromodeoxyuridine (BrdU) labeling (Gage, 2000). Unfortunately, this mode of study is not as 
effective as in vitro studies. They do not provide adequate statistics, and the full spectrum of 
neuronal cell phenotypes are often underrepresented (Gage, 2000). Additionally, labeling studies 
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can be inefficient because the labeling solution becomes diluted as cells proliferate (Gage, 2000). 
Information from all these studies helped us formulate a general idea of the molecular 
mechanisms required to model the differentiation  / proliferation changes from embryonic stem 
cells towards neuronal stem cell phenotypes. Our goal is to synthesize information, and 
overcome the disconnectedness apparent in this field of inquiry,   
 
Computational modeling of neural stem cell differentiation 
All of these pathways and transcription factors are brought into play when researchers 
formulate computational models to quantify and analyze the internal functions and behaviors of 
stem cells. According to Jacob Hanna, there are “Deterministic vs Stochastic” processes in 
modeling (Hanna et al. 2009). This 
refers to the fact that there is a lot 
of difficulty in formulating a model 
that accounts for what is expected 
versus what is random in cellular 
function.  
 In this study, we focused on 
the developmental pathway of a 
neuron from its embryonic state 
(Figure 7). Our first goal was to 
understand how embryonic stem 
cells maintain pluripotency, as well 
as how they proliferate. To this 
Figure 7: Embryonic stem cell lineage. Blue boxes connected 
by bold lines represent the lineage cascade that leads to neuronal 
specification. Red boxes represent lineages that have no 
ectodermal origin, while the green box represents the non-
neuronal lineage of the ectoderm. 	
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end, we have built a dynamic Boolean computational model to predict how maintenance and 
proliferation are coordinated, as well as how differentiation (loss of the ESC state) affects the 
signals that drive proliferation. Second, once we bridged the embryonic stem cells to the epiblast 
gap, we went on to analyze the molecular processes that ultimately determine the lineage of the 
embryonic stem cell; whether it becomes ectodermal, or enters a dermal layer of the primitive 
streak (Figure 7).  
Once we have determined the cellular characteristics of the ectoderm, we know that it 
differentiates into two lineages as seen in Figure 7. The lineage that we focused our modeling 
efforts on is the neural ectoderm. These cells further differentiate into two lineages, the neural 
crest giving rise to the peripheral nervous system, and the neural tube giving rise to the central 
nervous system. In order to understand this cascade, we first need to focus on the developmental 
biology of the early stages of embryogenesis in the future.  
 We decided to model this concept through the use of a Boolean model. Boolean modeling 
is a qualitative technique of studying the dynamic regulatory and signaling networks of large 
systems, without the need of previously known synthesis and degradation rate parameter for 
every biochemical interaction (Wang et al., 2012). It also serves as a functional foundation of 
combining and correlating relationships. Boolean models are capable of predicting effective 
interventions that could impact these relationships. The effectiveness of this particular modeling 
method is dependent on the availability of dynamic information, the size of the systems, and the 
types of questions that are addressed. The Boolean model is limited in terms of predicting 
precise, quantitative information with respect to concentration changes in small systems. 
However, it makes up for this shortcoming by providing excellent qualitative information on 
large networks, where building detailed, quantitative models is rarely feasible. We chose this tool 
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to study all the intercellular relationships of a proliferating and differentiating embryonic stem 
cell, resulting in a Boolean regulatory model with 69 nodes.  
In addition to building predictive regulatory models, Boolean modeling can also be used 
for reverse engineering regulatory relationships from cell-wide gene expression data (Wang et al, 
2012). These models help bridge the gap between static network representations of regulation, 
and detailed, continuous dynamic models that track individual molecule concentrations as a 
function of time. In relation to our study, Boolean models are capable of modeling gene 
regulatory and signaling networks (Wang et al, 2012). More importantly, Boolean models have 
been previously attempted to study embryonic stem cell fate control (Herberg et al, 2015), as 
well as embryonic stem cell maintenance in the presence of the transcription factors Oct4 and 
Sox2 (Herberg et al, 2015).  Lastly, there have been preliminary studies on the overall nature of 
embryonic stem cells in regards to the interaction network of ground state transcription factors 
(Martello et al, 2014).  
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METHODS 
Characteristics of synchronous Boolean models 
In order to systematically synthesize information about the mechanisms driving 
embryonic stem cell differentiation and proliferation, we used a mechanistic modeling approach. 
This refers to a series of steps in which we test the relationships among known regulatory 
connections as they work in concert. The first step is building a Boolean network model of a 
regulatory process. Once this has been completed, the next step is to simulate the model’s 
dynamical behavior in different environments and under changing stimuli, and to test these 
results against known experimental data. Once the known cell states and behaviors conform well 
to the model, we are able to test scenarios that have not yet been tested, leading to new 
predictions and new proposed experiments. 
As previously stated, each component in the model shares a unique relationship with all 
of the other components (also referred to as nodes), either providing direct effects or downstream 
effects to other nodes. In Boolean modeling, each node exhibits a binary behavior, which can be 
described as being 0 or 1. Components that are OFF (repressed or inactivated) are represented 
with a 0 whereas nodes that are ON (activated) are represented with a 1. Each node either 
represents a specific protein’s availability (e.g. BMP), an active transcription factor (e.g. SMAD 
or Sox2), or the activation state of a protein (e.g. pRB or p27Kip1).  The different expressions of 
activation and inactivation of these nodes represent a multitude of different cell states. However, 
only a few of these states are stable, in that the state of each node is consistent with the incoming 
regulatory signals from their upstream neighbors. These robust states (or cycles) correspond to 
cell phenotypes, such as Naïve ESC’s or Primed ESC’s.  A subset of nodes in our model 
represent input stimuli, corresponding to different environmental factors that affect the behavior 
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of the core model.  There are 4 such input stimuli in our model: BMP, LIF, 2i, and GF_High. 
These specific nodes are manipulated to stay in the ON or OFF state, whereas the other nodes 
change their expression (dynamic behavior) based on the activity of the input stimuli.  The 
manipulation of the input stimulus nodes changes the expression of the core nodes in the rest of 
the model.  
 Our final Boolean model consists of a total of 69 nodes. The behavior of each node is 
dictated by a Boolean regulatory gate. Each Boolean gate consists of the actual singular node 
being influenced (output node) and all of the different nodes that influence that specific node’s 
expression (input nodes). Each individual gate’s input and output nodes, as well as their 
relationships and information sources, can be found in the Supplementary Information Appendix.  
 The precise effects on the expression of the input nodes based on the expression of the 
output nodes can be characterized using binary conditional statements expressed as AND, NOT, 
and OR relationships. Figure X shows how each of these conditional relationships combine the 
effect of input nodes (X and Y), and affect the output node (Z). 
 
Figure 8. Simple Boolean gates using only AND or OR. These are two simple Boolean 
commands of 2 input nodes (X and Y) using only AND or OR which influences the activity of 
output node Z. 
 
Z	=	X	AND	Y	
X	 Y	 Z	
0	 0	 0	
0	 1	 0	
1	 0	 0	
1	 1	 1	
Z	=	X	OR	Y	
X	 Y	 Z	
0	 0	 0	
0	 1	 1	
1	 0	 1	
1	 1	 1	
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In this specific example, nodes A and B represent input nodes, while node C represents 
the output node. The relationship of node A and node B as well as their synergistic relationship 
with C affects the outcome in output node C. Looking at Figure 8, it is simple to discern the 
functional meanings of AND and OR. State AND signifies that both input nodes X and Y are 
needed to activate Z. State OR signifies that input node X and input node Y can both 
independently or work synergistically to activate output node Z 
 There are also four Boolean commands that combine the effects of AND and OR with 
repressive signals. These four specific complex commands are highlighted in Figure 9.  
 
Figure 9. Complex Boolean involving NOT. Four complex Boolean commands of 2 input nodes 
(X and Y) using AND, OR, and NOT which influences the activity of output node Z. 
 
When analyzing Figure 9, it is easy to discern the effect of adding NOT to the command. Any 
state including NOT signifies that there must be an absence of either input node X or input node 
Y, representing repressors, in order for output node Z to be activated.  
Z	=	X	AND	(NOT	Y)	
X	 Y	 Z	
0	 0	 0	
0	 1	 0	
1	 0	 1	
1	 1	 0	
Z	=	X	OR	(NOT	Y)	
X	 Y	 Z	
0	 0	 1	
0	 1	 0	
1	 0	 1	
1	 1	 1	
Z	=	NOT	(X	AND	Y)	
X	 Y	 Z	
0	 0	 1	
0	 1	 1	
1	 0	 1	
1	 1	 0	
Z	=	NOT	(X	OR	Y)	
X	 Y	 Z	
0	 0	 1	
0	 1	 0	
1	 0	 0	
1	 1	 0	
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 When considering Boolean modeling, it is important to acknowledge the assumptions that 
are associated with this model. When a node is OFF (0), it means that the node is completely 
inactivated. On the other hand, if a node is ON (1), this means that it is completely activated. 
This concept would impact the predictions of a Boolean model by differentiating it from a 
laboratory experiment in the sense that a model node (component) could not exhibit partial 
activation or inactivation.  In reality, the behavior of the same component often falls in between 
anywhere in the spectrum between complete activation and complete inactivation.  
 
Construction of the Boolean model 
Many interactions and regulatory relationships that provide the links of our model 
network can be found directly in scientific literature. Additionally, using the Boolean method, we 
determine the biochemical mode of activation of a node through the use of AND and OR. AND 
represents that the node requires the presence of two transcription factors to form a dimer while 
OR signifies that either input is known to be enough for the output activation. If the connection is 
not clear, we try both scenarios when manipulating the gate. The manipulations help formulate 
predictions of how the input and output nodes interact. Lastly, if no literature is present that 
describes the relationship between two nodes, a hypothetical relationship may be included, with 
the goal of showing that such a relationship is required for the system to remain consistent with 
experimentally observed cell behavior. 
 The overall procedure of Boolean model building is broken down into six main 
components. The first state is to formulate a network structure of the model (Wang et al, 2012). 
This is done by gathering previous research, and formulating a network of relationships between 
all the desired components of focus for the study. The next part is to code the state of each node 
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into its activation state in a binary fashion (Wang et al, 2012). Next, it is essential to study the 
causational information that leads to each node’s activity or inactivity. This can then be further 
analyzed to examine differences between multiple states of the model. Once this is done, it is 
important to test the correctness of the model. This provides validity to the experiment and 
provides a control to the experiment (Wang et al, 2012). Once this is done, father manipulations 
can be made to the model to form experimental predictions. Finally, based on previous findings 
provided by the model, it is possible to derive new biological implications, serving as a basing 
for future predictions and experimental studies (Wang et al, 2012).   
 
Identifying the stable states (phenotypes) of a Boolean model  
 Our first main goal was to match the phenotypes generated by the model to known 
biology. In order to do this, we used a random sampling procedure to find all stable states or 
cyclic behaviors the model can generate in the presence and absence of all its inputs, in every 
combination. As the full state space of possible initial conditions consists of 269 different 
combinations of node ON/OFF states, we used the sampling algorithm from Dr. David Deretei 
(Deretei et al., 2016), provided as a program in C++ by Dr. Erzsébet Regan.  Briefly, the 
algorithm places the Boolean model in a specific environment, then follows its dynamics in the 
presence of noise for T = 5 Boolean time-steps (perror = 0.02). At every step, the algorithm checks 
the attractor (stable state or cycle) the model would converge to in the absence of noise, and 
keeps track of each attractor as it discovers them. This process is repeated Nrnd = 100 times in 
every ON/OFF combination of the input signals (environmental conditions) of the network. Once 
the sampling was finished, we tested the model against known biological behavior of cells, and 
attempted to match the model’s stable states to those representing normal cellular function. 
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Simulating a change in the extracellular environment 
The purpose of this part of our in silico experiment is to test the response of the cell to a 
specific environmental change. To do this, our program generates a visual representation of the 
time-course by which the activity of each node changes over time in response to changes in 
environmental signals. First, a specific initial attractor state of interest is chosen, corresponding 
to a cell with a particular phenotype, and then the code runs a simulation where all of the other 
nodes in the model change their activity or expression in response to signals triggered by the 
environment.  
The extracellular inputs BMP, GF, GF_High, LIF, and 2i were each individually tested to 
see how their varying levels of expression for varying lengths of time alters the phenotype of the 
cell. The two cell phenotypes I was most interested in were naïve embryonic stem cells and 
neuroectodermal cells, exposed to signals that induce differentiation or attempt to reverse it. I 
also looked at whether these cells were in G0 or in the cell cycle. As a specific cell phenotype 
was tested, changes in its phenotype were monitored. The length of time where the cell either 
went thru apoptosis or exited the cell cycle into a G0 state was also monitored.  
Using the results of time-course simulations, we compared the model’s predictions to 
known behavior of cells under these environmental perturbations. Whenever we found 
discrepancies with the literature, or whenever the role of a node was not in accordance with its 
known activity pattern, we attempted to a change the regulatory gate of it, and restarted the 
sampling / validation process. Indeed, the misbehavior of the nodes can sometimes discredit 
some of the results of the model, so adjustments are needed to make the model as scientifically 
accurate as possible. If no plausible corrections or literature is present, assumptions need to be 
made about the expression of the node in its relationship to the expression of other nodes. This 
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can lead to novel predictions related to experimentally untested scenarios, but also point to 
severe gaps in the literature with respect to the mechanisms actually responsible for the behavior 
of cells. 
 
Biological processes not included in the model 
Many complex systems and relationships were either simplified or completely excluded 
from our model. For example, the BMP pathway is oversimplified by only including BMP, 
SMAD, and only one of many target genes repressed by SMAD, namely Zic1_3 (standing in for 
both Zic1 and Zic3). These components are crucial to the overall functional behavior of BMP 
activation and deactivation during neuroectoderm specification, but other contributing 
components critical for BMP signaling in other contexts were not included in the model.   
Additionally, the molecular mechanisms responsible for differentiation into, and 
maintenance of cell states beyond the cell types present in early neurogenesis were also not 
included. The model specifically looked for phenotypes representing naïve embryonic stem cells, 
primed embryonic stem cells, ectodermal cells, or other (unspecified) differentiated cells. The 
precise mechanisms by which these other differentiated cell types sort into distinct lineages is 
outside the scope of this study. 
Finally, details of processes such as DNA replication and the formation of the mitotic 
spindle apparatus (the execution of metaphase) are also not included. We know that DNA must 
be replicated in order to produce another cell, but we elected not to include the details of this 
mechanism, and encoded DNA replication through a Replication Node (denoting ongoing 
replication), and a 4N_DNA node denoting that Replication is complete (the cell has double the 
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normal amount of DNA). A similar method was used in accounting for the process of mitotic 
spindle assembly. 
Lastly, we also elected not to include the input signals that typically trigger apoptosis, 
such as death receptor signaling or DNA damage signaling. The model does, however, include 
the internal switch capable of committing cells to apoptosis, and it requires survival signals to 
stay in its “alive” state. We can thus determine if a cell is dead by checking the behavior of 
certain nodes such as CAD (Caspase-activated DNase), whose activation signifies irreversible 
commitment to programmed cell death. 
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RESULTS 
Modeling the embryonic stem cell state switch 
The main goal of this project was to add an embryonic stem cell pluripotency circuit to 
the preexisting cell cycle model adapted from Dr. David Deretei (Deretei et al., 2016) and the 
Independent Study thesis of Andrew Hamel (Hamel, 2016).  This pluripotency circuit is crucial 
not only to establishing embryonic stem cell states, but its alternate behavior can allow for the 
embryonic stem cell to differentiate into a more specific cell type. By incorporating this circuit, 
most notably involving Oct4, Sox2, and Nanog transcription factors, we were able to generate 
different phenotypes based on the different expressions of those specific transcription factors. 
The known biology that we were able to model were the naïve embryonic stem cell state and the 
neuroectodermal cell state.  
 There were a multitude of difficulties associated with the construction and modeling of 
this circuit. The first difficulty was simulating the behavior of Sox2 and Oct4’s relationship. In 
the case of these transcription factors, neither really follows the binary logic of being completely 
activated to completely repressed. There are cases where Oct4 can be activated while Sox2 is 
inactivated and vice versa. This isn’t necessarily congruent with scientific literature as neither 
factor is ever completely suppressed. To combat this difficulty, it was decided to create a node 
that shared the characteristics of each of those nodes. Therefore, the Oct4_Sox2 node was 
included to aid manipulation of Oct4 & Sox2 expression since neither one fully go away despite 
the binary characteristics of the nodes. 
 The next step was to figure out how to connect the pluripotency circuit with the rest of 
the preexisting model. We chose to include Klf4 in the model since it plays a role in cell 
proliferation and differentiation and it is directly linked with a few of the crucial nodes in the 
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core of the cell cycle model. In this model, Klf4 is connected and shares a relationship with 
Stat3, Myc, and the ERK pathway. Stat3 is critical for its roles in both cell growth and 
prevention of apoptosis. The Klf4 node was added in an interaction with Stat3, which tied in this 
circuit with the LIF input. This was critical because it tied in the LIF input stimulus with the rest 
of the pluripotency circuit, as well as the rest of the cell cycle model. Additionally, Esrrb was 
added in relation to Oct4 and Nanog to tie it in with B_Catenin and GSK3, involved with cell 
cycle regulation by controlling AKT activity. 
 There were a few possible exterior nodes associated with embryonic stem cell 
pluripotency circuit which were left out. We elected to only include Sox2 from the Sox family of 
transcription factors, as it had the largest influence in pluripotency in embryonic stem cells. This 
specific Sox was discussed in the literature significantly more than any other member of its Sox 
family, and its role is better understood. The case was the same for Klf4, as Klf4 has a much 
greater influence on the pluripotency circuitry than other member of the Klf gene family.  
Lastly, ectodermal lineage commitment nodes such as Otx1, Ectodermin and Hoxb1 were 
not included because our focus was on distinguishing the neuroectoderm from other 
differentiated cell types. Additionally, Micah Auerbach’s Independent Study project focused on 
the effect of lineage-specific factors such as Gata6 and Cdx2, allowing him to model 
commitment to the endodermal as well as trophoblast lineages. As the first step in neurogenesis 
is the specification of neuroectoderm by the absence of active BMP signaling in the central 
portions of the neural plate, our focus was modeling the effect of a BMP environment, and a 
lineage-specific factor downstream as readout for neuroectoderm specification. While there is 
scientific literature related to other nodes or factors that could influence the behavior of our ESC 
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module, we elected to stick with the core circuitry of ESC maintenance, and modeled its critical 
connections to other cellular functions such as the cell cycle and survival/ apoptosis.  
 
Modeling Growth Factor (GF) signaling 
Following the work of Andrew Hamel, we modeled the mitogenic influence of the 
fibroblast growth factor FGF by connecting it to its receptor (RTK, here denoting FGFR 
proteins) and the generic RTK-responsive Gbx2 adaptor. These nodes then simulate progression 
through the cell cycle by activating AKT as well as MAPK signaling. In order to model three 
distinct mitogenic environments, namely the absence of growth factors, a low level capable of 
sustaining survival but not proliferation, and a higher level that drives the cell cycle, the growth 
factor input was separated into two different Boolean input nodes, GF_High and GF. Thus, GF = 
ON represents the basic level of mitogens needed for a cell to survive, while GF_High represents 
the amount of mitogen needed for the cell to grow and proliferate. We modeled this by making 
GF self-sustaining, so that we could initialize it ON or OFF. In addition, GF_High activity (also 
self-sustaining) automatically turned the GF node ON.  
The core of the growth factor signaling pathway modeled by Andrew Hamel (Hamel, 
2016) was present (PI3K/AKT pathway as well as the MAPK/ERK pathway), but we chose to 
exclude the DNA damage signaling module, along its ability to arrest the cell cycle via Chk1 and 
Chk2 (the latter is also connected with apoptotic pathways).  
The inclusion of the GF and GF_High inputs the rest of the growth factor signaling 
pathway worked as expected. GF ON was largely responsible for most cells being alive, although 
its activation was not always required for the cell to self-sustain (i.e., LIF could also provide the 
necessary survival signal; see below). GF_High ON, in contrast ensured that cells could undergo 
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the cell cycle. There were no attractor states where the cell was able to proliferate without the 
presence of either GF_High or LIF.  
 
Modeling the Leukemia Inhibitory Factor (LIF) switch 
The LIF input signal triggers the activity of its receptor, LIFR, which connects it to the 
PI3K/AKT and Stat3 pathways. LIF ON signifies the presence/activation of environmental LIF. 
When LIF is present, LIFR mediated PI3K/AKT activation contributes to survival, cell growth, 
cell cycle entry, and subsequent proliferation. LIFR ON also activates Stat3, which directly 
influences the Oct4/Sox2/Nanog embryonic stem cell pluripotency circuit. In this specific model, 
Stat3 directly influences Sox2 and Klf4.  The link to Klf4 is critical, as Klf4 is involved in the 
regulation of proliferation by activating Myc and allowing cells to self-renew even in the absence 
of active MAPK signaling. Sox2, in contrast, is involved in maintaining pluripotency in 
embryonic stem cells. 
We believed that the inclusion of LIF into the model would help explain how it can 
promote proliferation and inhibit differentiation at the same time. The goal of adding LIF to the 
model was to see if this same concept applied to naïve embryonic stem cells in terms of staying 
naïve or differentiating into the ectodermal lineage. Indeed, in our model, LIF OFF is associated 
with differentiation, and LIF ON is generally associated with cell proliferation without 
differentiation. 
 A few molecular connections were left out of the modeled LIF pathway. First, the JAK 
kinase was not explicitly included along the JAK/Stat pathway. JAK would have represented a 
single step between LIFR and Stat3, and thus its explicit inclusion wasn’t necessary. The other 
biology that wasn’t included relates to other factors that can inhibit LIF by blocking its receptor, 
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such as SOCS3 (White & Nicola, 2013). This could have potentially have altered the number of 
live attractor states created by the model. Additionally, we did not include the effect of LIF and 
LIFR on the Grb2 node. In our model, Grb2 activates the MAPK, which would inhibit Tbx3 and 
which is known to be OFF in embryonic stem cells. If Tbx3 was inhibited, then Tbx3 would be 
incapable of activating Nanog. This indicates that either the LIFR → Grb2 connection, or the 
Grb3 → MAPK connection is influenced and even blocked by unknown signals internal to 
ESCs. With the exception of Grb3, there were no difficult gates in constructing this specific 
module. LIF is self-sustaining, and LIFR is always activated as long as LIF is ON. 
 There weren’t any redundancies with this specific module within the model. The only 
thing that I would have changed was to remove the LIFR node. The LIFR node’s behavior 
models and parallels the behavior of the LIF node. The addition of this extra node was a bit 
unnecessary, especially since there wasn’t an effort to include any other receptor nodes for the 
other stimuli in the model.  
 The inclusion of LIF and LIFR worked well with the rest of the model. When LIF was 
ON it prevented the cell from differentiating, but it mostly impacted if the cell could proliferate 
or not. LIF ON was able to drive the cell cycle in any environment where it was present. 
Essentially, the cell could live with LIF ON and GF OFF in terms of self-sustainment. On the 
other hand, if LIF was OFF, the probability that the cell could differentiate significantly 
increased.  
 
Modeling the 2i switch 
We included the 2i environment stimulus node because experiments clearly indicate that 
the presence of 2i adds additional robustness to the embryonic stem cell state. The goal of this 
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inclusion was to see how the presence of 2i would impact the cell when it is functioning on its 
own as a sole pluripotency factor, as well as how it works with other factors attempting to keep 
the cell pluripotent. Additionally, we wanted to see how 2i ON could influence differentiation 
triggered by other stimuli.  
  2i stands for a cocktail of 2 chemical inhibitors used in ESC cell culture in the laboratory, 
usually in conjunction with serum and LIF. 2i has the ability to inhibit the MEK and GSK3 
kinases, which helps maintain the embryonic stem cell state. Thus, there were no difficulties with 
incorporating 2i into the model. The 2i gate is only connected to two nodes, MEK and GSK3, 
and it acts to inhibit both. The difference between 2i and LIF is that 2i prevents differentiation as 
well as growth-factor-driven proliferation, whereas LIF not only prevents differentiation, but it 
also promotes the cell cycle. This was due to the fact that in instances where 2i is ON and 
GF_High is also ON, the presence of 2i outweighs the presence of GF_High and MEK remains 
OFF.  
 
Modeling the Bone Morphogenetic Protein (BMP) switch 
BMP is a critical transcription factor needed for the onset of neurogenesis. We 
hypothesized that its absence would help trigger ESC differentiation into the neuroectodermal 
lineage. The goal was to simulate the biological scenario where BMP’s activation triggers the 
cell differentiation cascade, pushing the cell to the ectodermal lineage, but then inactivating once 
the ectodermal cell forms for neuroectodermal cells to arise.  The ectoderm is the default fate if 
LIF goes away and GF is ON, regardless of BMP expression. Once the BMP goes away, the 
ectoderm arises. 
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 There were some difficulties with incorporating BMP signaling into our model, as 
different cell phenotypes and behaviors arise from varying levels of environmental BMP. High 
levels of BMP lead to the development of the ectoderm, while low levels of BMP allow for the 
development of the neuroectoderm. Additionally, BMP is needed once again later in 
neurogenesis within the neuroectoderm to produce a variety of neuronal types, while also 
suppressing neuroectodermal cells from falling in the oligodendroglial fate. Therefore, it was 
difficult to model BMP’s phenotypic effects outside of its initial push from the embryonic stem 
cells towards neuroectodermal cells. 
 There was some nodes and biology that was left out in the making of this module. First of 
all, TGF-Beta was left out of the model. TGF-Beta not only connected with BMP, but it is also 
signals to activate the downstream effectors of BMP signaling; the SMAD complexes. 
Additionally, TGF-Beta also activates MAPK, leading to downstream activation of the ERK 
pathway. Since BMP is already connected to SMAD and BMP activates ERK in the model, it 
was not necessary to include this node. Furthermore, no BMP antagonists were included, such as 
Chordin and Follistatin. As BMP serves as an input environmental stimulus to the model, adding 
another environmental signal just to inhibit it would have been redundant. We also did not 
include any mechanisms that inhibit SMAD function, or of its targets outside its inhibitory 
effects on the transcription of two neuroectoderm-specific transcription factors Zic1 and Zic3. 
Lastly, although we have a growth factor input in our model, we did not include 
fibroblast growth factor’s (FGF) ability to down regulate BMP (Srinivasan et al., 2014), which 
would promote neural ectoderm formation. This would be an interesting complex/module to 
include in the model in the future, as it would serve as a direct link for BMP inhibition. This 
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could potentially make it clearer how BMP works with other factors. In our current model, we 
only looked at what would happen if BMP were completely active or completely inactive.  
SMAD was included as a generic complex standing in of all of the SMAD proteins 
involved in the BMP pathway. Although there are multiple SMADs, they all work in unison to 
transmit the same signal, so it was unnecessary to add each individual SMAD. Its main influence 
considered here was its effect on Zic1 and Zic3 transcription. Since the two Zic proteins have a 
similar function in this cascade (Janesick et al., 2013), we kept the model simple by including a 
single node that represents both proteins. Zic1 and 3 impact neural proliferation and neural 
differentiation, as it activates Geminin, a replication origin licensing factor critical for cell cycle 
progression (Janesick et al., 2013).  
 In our model, BMP served as an input stimulus that inhibits ERK, activates SMAD and 
thus inhibits the Zic1_3 complex. In its absence, Zic1_3 can be activated by ERK. As BMP’s 
activity directly blocks ERK, this means that BMP can indirectly inhibit Zic1_3 even in the 
absence of SMAD activation. BMP’s activation also outweighs growth factor signaling in terms 
of its control on ERK.  
The processes that lock in Zic1_3 activity and by extension, the neuroectodermal fate 
proved really difficult to model. The literature yielded no clues as to the molecular mechanisms 
could prevent a differentiated neuroectodermal cell, with Zic1_3 activity and no 
Oct4/Sox2/Nanog activity, from reverting to an embryonic stem cell state once the 
environmental signals of differentiation were removed. To remedy this, we attempted to make 
Zic1_3 self-sustaining. This is not only artificial, but it fails to block the ESC core circuit from 
reengaging. Overall, although we couldn’t encapsulate all of BMP’s behavior on the variety of 
phenotypes it is associated with, we were still able to model its main effect on embryonic stem 
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cells, leading to neuroectodermal cells. We were not able to capture a stable, primed embryonic 
stem state (primed ESC cells have Oct4/Sox2, but no Nanog), but we were able to model naïve 
embryonic stem cells and neuroectodermal cells.  
 
The healthy embryonic stem cell phenotype 
Our full network model can be seen on Figure 10, showing the naïve embryonic stem cell 
phenotype as it is finishing DNA replication, in an environment with a high level of mitogens 
(GF_High ON), LIF and 2i ON and BMP OFF. In general, state is dependent on pluripotency 
inducing input stimuli such as 2i and LIF, and the absence of BMP. 
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Figure 10. Phenotypic representation of a healthy Naïve ESC in cell cycle. (#83). All environments ON except 
for BMP. Orange circles signify activation and blue circles represent repression. 
 
 
The healthy neuroectodermal phenotype 
The healthy ectodermal state can be present when BMP is ON, which pushes ESCs 
towards the ectodermal lineage, but in order for the neuroectodermal lineage to stabilize, BMP 
needs to turn OFF. The phenotype shown on Figure 11 represents a neuroectodermal cell that 
lacks any pluripotency circuit activity. Here, GF_High is IN and LIF, 2i, and BMP are OFF. 
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Figure 11.  #45. Boolean model of a healthy neuroectoderm cell in cell cycle. GF & GF_High ON only. Orange 
circles signify activation and blue circles represent repression. 
 
GF allows the cell to survive and self-sustain, and GF_High allows it go grow and proliferate. 
The absence of BMP allows the maintenance of the neuroectodermal lineage. Additionally, the 
absence of LIF and 2i block the phenotype from having any naïve ESC characteristics.  
 
The apoptotic phenotype 
In the model, apoptosis was triggered by the loss of all survival signals. This involved the 
inactivation of growth factor signaling. This source attributes to the most amount of deaths 
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among the stable attractors produced by the model. Although the cell could survive without GF if 
LIF was present, LIF could be overpowered by BMP, which would cause the cell to die.  
 The second source of apoptosis was the activation of apoptosis inducing agents such as 
CAD. If CAD or any other nodes in the apoptosis circuit was activated, the cell was certain to die 
regardless of other input environmental stimuli present and phenotype.  
 
Sampling all stable phenotypes of the model 
In a sample size of N = 400 initial conditions, a total of 236 stable states were produced. 
Of the 236 produced attractors, 95 represented naïve ESC’s, 0 represented primed ESC’s, 2 
represented neuroectodermal cells, 21 represented neuroendodermal cells, and 118 were dead.  
In order to test the environment-dependence of these phenotypes, we categorized them 
based on the combination of environments they were placed in. First, we separated them based 
on the state of BMP. Based on each BMP environment, different scenarios where the 
combinations of LIF, 2i, and GF/GF_High. First we looked at the different cell phenotypes that 
could arise in the BMP OFF condition, shown in Figure 13. 
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Figure 13. Stable phenotypes of the model in all possible BMP-OFF environments. The attractor states were 
determined by extensive sampling of cell phenotypes based on twelve possible combinations of inputs: absence or 
presence of LIF, absence or presence of 2i, and three levels of growth factor input. 
 
The BMP OFF environment was able to sustain five different cellular phenotypes. The 
first and obvious one was cell death, or apoptosis (Figure 13, brown D). Theoretically, death 
could occur from any phenotype in any combination of the input environments. In addition, 
death was certain (the only option) if the cell was exposed to an environment of LIF OFF and GF 
OFF.  
The next phenotype is the Naïve ESC undergoing cell cycle (Figure 13, blue with cell 
cycle). This phenotype is stable in 5 different conditions. Namely, each of these environments 
have LIF ON, with varying states of 2i and GF. The only scenario where a LIF ON environment 
could not sustain the Naïve ESC state was when GF_High was ON and 2i was OFF. This results 
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is in agreement with the experimentally documented role of 2i in stabilizing the ESC state in the 
presence of FGF signaling.  
The next set of phenotypes represent Naïve ESCs in G0 (quiescent state) (Figure 13, blue 
with G0), as well as differentiated cells at G0 (Fig. 13, orange with G0). Both of these cell types 
are stable if LIF is OFF, or, alternatively, in either a GF/GF_High ON environment with 2i ON, 
or a GF ON/2i OFF environment. As our model does not explicitly includes the circuit required 
to commit to other lineages outside the neuroectoderm, the differentiated state is a stand-in for 
other cell types where the ESC circuit has been turned off. 
The final phenotype of note is that of a neuroectodermal cell (Figure 13, green). This 
phenotype could arise in two conditions; in the presence of strong growth signaling with no ESC 
maintenance signals (GF_High ON, 2i OFF, and LIF OFF), in a GF_High, LIF ON, but 2i OFF 
condition. This is consistent with the fact that in the presence of active MAPK signaling (where 
the ESC circuit is destabilized), LIF is responsible for maintaining neural stem cells (i.e. 
neuroectoderm). 
After we analyzed the BMP OFF condition, we studied the effect of turning BMP ON. 
After carefully sampling the model in the BMP ON condition, only three different phenotypes 
were stable across all other input environments, as shown in Figure 13.   
Of the three stable phenotypes produced by the model in the BMP ON condition, the 
Naïve ESC (Figure 14, blue) was the most prevalent. With BMP ON, this cell type only required 
a minimal amount of survival signaling, either from LIF or GF. Additionally, these naïve ESCs 
proliferated in the presence of LIF or GF_High, and remained quiescent (G0) in no-LIF low GF 
conditions. 
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 The next stable phenotype present was the differentiated cell in G0 (Figure 14, orange). 
This phenotype could not be maintained in the presence of LIF, pointing to the lack of adequate 
negative feedback from the differentiated state towards the ESC factors (thus, LIF can re-activate 
them). Lastly, cell death (Figure 14, brown D) could theoretically occur and is stable in any 
condition.  
 
Figure 14. Attractor states of a naïve embryonic stem cell in a BMP ON environment. The attractor states were 
determined by extensive sampling of cell phenotypes based on twelve possible combinations of inputs: absence or 
presence of LIF, absence or presence of 2i, and three levels of growth factor input. 
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look deeper into all the molecular changes that occurred due to change of expression downstream 
these environmental stimuli. Every time a time course experiment was conducted, a stable 
phenotype, such as Naïve ESC’s in G0 or Ectodermal cells in cell cycle, was chosen first. This 
stable phenotype was then exposed to a pulse of GF, GF_High, 2i, LIF, or BMP. The resulting 
activation and inactivation of the rest of the nodes is then shown as a function of time. These 
time course plots show the coordinated dynamic changes that occur within the cell over time.  
 To deal with the combinatorial explosion from all possible environmental changes from 
every possible starting state, we first automated the identification of the initial-final state pairs 
for every change, then analyzed all of the biologically relevant phenotype changes in more detail. 
The aim of these experiments was to analyze how the dynamical behavior of the nodes within the 
cell can change the cellular phenotype, especially in response to transient stimuli. 
 
Changing the 2i environment.  
The first input we looked at was 2i. Figure 15 shows cell phenotype transitions from one 
attractor to another from each initial condition, in the presence of varying levels of LIF, 2i, and 
GF, as well as the presence or absence of BMP.  
 In the presence of BMP (BMP ON), a change in 2i does not result in any interesting cell 
phenotype transitions (thin red arrows). Regardless of high or low levels of 2i, cell phenotypes 
involved with Low GF or High GF and LIF remained the same. In the presence of NO GF and 
NO LIF, the cell dies regardless of the presence or absence of 2i.  
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Figure 15. Changes in cell phenotypes dependent on 2i presence or absence. After extensive sampling, stable 
phenotypes were analyzed how they changes based on the addition or removal of 2i from the environment.  
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into the Naïve ESC state, based on the expression of 2i. This is not a biological behavior; in vitro 
or in vivo differentiated neuroectodermal cells are incapable of reverting back to their embryonic 
stem cell state. In the model (and in the literature), however, there is no known feedback 
mechanism to prevent the Oct4/Sox2 circuit from re-engaging. Second, a neuroectodermal cell in 
cell cycle is present in the GF_High ON, 2i OFF and LIF OFF condition. If 2i is turned ON, this 
cell looses its neuroectoderm characteristics, but does not de-differentiate. Moreover, cells in a 
Naïve ESC and G0 state differentiate into neuroectoderm upon loss of 2i, but do not revert when 
2i is turned back on. The behavior of the Naïve ESC is consistent with known biology.  
To show the molecular dynamics driving this phenotype change, we took a deeper look at 
the 2i change from attractor state 229, the Naïve ESC, in response to a pulse of 2i deactivation 
(Figure 16). This time course starts with a Naïve ESC in G0 in a GF ON, GF_High ON, 2i ON, 
LIF OFF, BMP OFF environment. This Naïve ESC in G0 becomes a neuroectodermal cell when 
2i is turned OFF. When 2i is subsequently turned back ON again, the neuroectodermal cell will 
become a non-neuronal (generic) differentiated cell in G0. Initially when 2i is ON, the Naïve 
ESC in G0 has an active pluripotency circuit; Oct4, Sox2, and Nanog are all ON. In the period 
where 2i is turned OFF, the pluripotency circuit is turned OFF, which pushes the cell to 
differentiate and there is an absence of any cycling behavior. BMP is blocking ERK and there is 
no LIF to compensate. Once the Naïve ESC in G0 commits to becoming a neuroectodermal cell, 
it is unable to revert to its naïve ESC via a change in 2i. 
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Figure 16. Attractor 229 - Phenotypic transitions from a Naïve ESC in G0 response to transient pulses of 2i. A 
30 time step pulse of 2i affecting a Naïve ESC in G0. Orange blocks signify activation and blue blocks represent 
repression. Each column represents a time-point in the simulation. 
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Changing the LIF environment 
The second input stimulus we looked at was the LIF environment. By looking at the 
figure, we compared cell phenotypes in each condition in the presence of varying levels of LIF, 
2i, and GF in the presence or absence of BMP. Figure 17 exhibits how each phenotype can “flip” 
or is related in based on the presence or absence of LIF. 
 
Figure 17. Changes in cell phenotypes dependent on LIF presence or absence. After extensive sampling, stable 
phenotypes were analyzed how they changes based on the addition or removal of LIF from the environment.  
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 The models created in the presence of BMP ON and BMP OFF produced some expected 
results. In both BMP conditions, if LIF was removed from a Naïve ESC in cell cycle in a LIF 
ON GF OFF condition, the cell would die. Additionally, if a Naïve ESC in a LIF ON and GF ON 
(both GF and GF_High) condition were moved into a LIF OFF condition, the phenotype would 
change to a Naïve ESC in G0. Therefore, the presence or absence of LIF determines if a Naïve 
ESC is either in cell cycle or G0. These two phenotypes are completely capable of toggling back 
and forth.  
 When looking at LIF expression, the model also produced some interesting results. First 
of all, in the BMP OFF condition the presence or absence of LIF did not cause any effect on the 
ectodermal cells in cell cycle. This was inconsistent with the Naïve ESC’s exposed to LIF 
variations if GF was ON, as LIF OFF in this condition would put the cell in G0. Additionally, the 
Differentiated ESC’s in G0 acted improperly. The model shows these cells can revert back to 
their naïve state and initiate a cell cycle in the presence of LIF. This result was further analyzed 
using a transient pulse of LIF in attractor state 109 in Figure 18.  
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Figure 18. Attractor 109 - Phenotypic transitions from a differentiated ESC in G0 response to transient 
pulses of LIF. A 30 time step pulse of LIF affecting a differentiated ESC in G0. Orange blocks signify activation 
and blue blocks represent repression. Each column represents a time-point in the simulation. 
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cell will become a Naïve ESC in G0. The differentiated ESC in G0 starts cell cycling as soon as 
LIF is ON. This cell then completes three full cell cycles until LIF is turned OFF. Once LIF is 
turned OFF, the cell cycling stops but the cell then resembles a Naïve ESC in G0 in the absence 
of LIF. The Naïve ESC in G0 and the Naïve ESC in cell cycle are interchangeable based on 
LIF’s expression. Once the differentiated ESC in G0 commits to a Naïve ESC in cell cycle, it can 
never become a differentiated ESC ever again. 
 
Changing the GF environment 
The third input stimulus we looked at was the GF environment. Once again, we compared 
cell phenotypes in each condition in the presence of varying levels of LIF, 2i, and GF in the 
presence or absence of BMP. Figure 19 exhibits how each phenotype can “flip” or is related in 
based on the presence or absence of GF. 
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Figure 19. Changes in cell phenotypes dependent on GF presence or absence. After extensive sampling, stable 
phenotypes were analyzed how they changes based on the addition or removal of GF from the environment.  
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GF was present or absent. This makes sense because the cell can still live and survive off of LIF. 
Adding or removing GF to a Naïve ESC in G0 would not alter its phenotypic expression. 
The fourth input stimulus we looked at was the GF_High environment. We analyzed cell 
phenotypes in each condition in the presence of varying levels of LIF, 2i, and GF in the presence 
and absence of BMP. Figure 20 below exhibits how each phenotype can “flip” or is related in 
based on the presence or absence of GF_High. 
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Figure 20. Changes in cell phenotypes dependent on GF_High presence or absence. After extensive sampling, 
stable phenotypes were analyzed how they changes based on the addition or removal of GF_High from the 
environment.  
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OFF conditions. The level of GF expression (GF and GF_High) did not impact the phenotypes of 
these cells.  
 The GF_High manipulation model also illustrated some interesting results in the BMP 
OFF condition. The results were the same as the BMP ON condition except for the conditions 
where 2i is OFF. In the 2i OFF LIF ON condition, the model shows that an ectodermal cell in 
cell cycle can toggle back and forth with a Naïve ESC in cell cycle based on the level of GF 
expression. This cannot happen as a Ectodermal cell is incapable of reverting back to its 
pluripotent ESC state. The other interesting result shown in this model is that a Naïve ESC in G0 
and a Differentiated ESC in G0 in a 2i OFF LIF OFF GF ON condition can be pushed to 
becoming a ectodermal cell in cell cycle if GF ON moves to GF_High ON. Unlike the GF_High 
ON 2i OFF LIF ON condition, the ectodermal cell will not move back to its previous state in this 
condition, which is consistent with biology. To account for this unexpected change, we took a 
deeper look at attractor state 149 in Figure 21.  
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Figure 21. Attractor 149 - Phenotypic transitions from a Naïve ESC in G0 response to transient pulses of 
GF_High. A 30 time step pulse of GF_High affecting a Naïve ESC in G0. Orange blocks signify activation and blue 
blocks represent repression. Each column represents a time-point in the simulation. 
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cycle is established, if GF_High is removed the ectodermal cell in cell cycle becomes a 
differentiated cell in G0. Initially, GF_High is OFF and the Naïve ESC in G0 exhibits an ON 
pluripotency network and no cell cycle. Once the GF_High turns ON, the pluripotency circuit 
turns OFF, allowing the cell to differentiate into a Ectodermal cell in cell cycle. Additionally the 
cell is able to complete three full cell cycles. Once GF_High is turned back OFF, the Ectodermal 
cell in cell cycle becomes a differentiated ESC in G0. This is illustrated by showing that the 
pluripotency circuit and cell cycling nodes remain OFF. Once the Naïve ESC in G0 becomes an 
ectodermal cell in cell cycle, it cannot revert back to its naïve phenotype. However, the 
ectodermal cell in cell cycle and differentiated ESC in G0 phenotypes can toggle back and forth 
based on the expression of 2i. 
 
Changing the BMP environment 
The last input stimulus we looked at was the BMP environment. By looking at the figure, 
we compared cell phenotypes in each condition in the presence of varying levels of LIF, 2i, and 
GF in the BMP ON and BMP OFF conditions. Figure 22 exhibits how each phenotype can “flip” 
or is related in based on the presence or absence of BMP. 
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Figure 22. Changes in cell phenotypes dependent on BMP presence or absence. After extensive sampling, stable 
phenotypes were analyzed how they changes based on the addition or removal of BMP from the environment.  
 
 The BMP manipulation model shows how cell phenotypes can change based on the 
addition or removal of BMP from the environment. As seen in the figure, all cell phenotypes 
remain the same except for three conditions if they are flipped between BMP ON and BMP OFF. 
These unique changes occur in the 2i OFF GF_High ON LIF ON condition and the 2i OFF 
GF_High ON LIF OFF condition. In the 2i OFF GF_High ON LIF ON condition, the cell 
No GF
2i
Low GF High GF
LIF
No 2i
No LIF
D
D
D
D
D
D
D
BMP OFF
G1 S G2
MA;C
Naive ESC
G1 S G2
MA;C
Ectoderm
D
G1 S G2
MA;C
Naive ESC
G1 S G2
MA;C
Naive ESC
D
G1 S G2
MA;C
Naive ESC
G1 S G2
MA;C
Naive ESC
D
Naive 
ESC
G0
G1 S G2
MA;C
Ectoderm
Diff.
G0
D
Naive 
ESC
G0
Diff.
G0
D
Naive 
ESC
G0
Diff.
G0
No GF
2i
Low GF High GF
LIF
No 2i
No LIF
D
D
D
D
D
D
G1 S G2
MA;C
Naive ESC
D
G1 S G2
MA;C
Naive ESC
G1 S G2
MA;C
Naive ESC
D
G1 S G2
MA;C
Naive ESC
G1 S G2
MA;C
Naive ESC
D
Naive 
ESC
G0
Diff.
G0
D
Naive 
ESC
G0
Diff.
G0
G1 S G2
MA;C
Naive ESC
D
Naive 
ESC
G0
Diff.
G0
D
Naive 
ESC
G0
Diff.
G0
BMP ON
BMP_Change
	-54-	
phenotype is an ectodermal cell in cell cycle in the absence of BMP, and it is a Naïve ESC in cell 
cycle in the presence of BMP. The model shows that the two cell phenotypes are able to toggle 
back and forth based on the presence or absence of BMP. This cannot happen as a 
neuroectodermal cell should lock in and not allow itself to revert to the Naïve ESC state simply 
due to BMP being present. Lastly, in the 2i OFF GF_High ON LIF OFF condition, a Naïve ESC 
in G0 will only change to a neuroectodermal cell in cell cycle if BMP is removed, which is what 
we desired to see. On the other hand, a Differentiated ESC in cell cycle phenotype is able to 
toggle back and forth with an neuroectodermal cell in cell cycle based on BMP expression. This 
cannot happen, as the neuroectodermal cell cannot revert back to a differentiated ESC. To 
account for this unexpected change, we took a deeper look at BMP change in attractor state 216 
in Figure 23.  
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Figure 23. Attractor 216 - Phenotypic transitions from a Naïve ESC in G0 in response to transient pulses of 
GF_High. A 30 time step pule of BMP affecting a Naïve ESC in G0. Orange blocks signify activation and blue 
blocks represent repression. Each column represents a time-point in the simulation. 
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G0 permanently moves to becoming an ectodermal cell in cell cycle. If BMP is turned back ON, 
the ectodermal cell in cell cycle becomes a differentiated ESC in G0. The model initially 
illustrates the Naïve ESC in G0 by having pluripotency nodes ON and having cell cycle nodes 
OFF. Once BMP is removed from the environment, the pluripotency circuit turns OFF, signaling 
differentiation, and the cell begins to cell. The cell cycles three times while BMP is OFF. Once 
BMP turns back ON, the pluripotency circuit cells remain off (signaling permanent 
differentiation) and the cell cycle nodes are also OFF, illustrating the G0 state. Once the Naïve 
ESC in G0 becomes a ectodermal cell in cell cycle, it is stuck in that phenotype. Nonetheless, the 
ectodermal cell in cell cycle and the differentiated ESC in G0 are not stuck in their phenotypes, 
as their states can toggle back and forth based on the presence or absence of BMP. 
 
Stable phenotypes after changing the Zic1_3 Gate so that it sustains its own activity 
 Once this analysis was completed and results were obtained, we decided to change the 
gate of the Zic1_3 node so that it could autoregulate itself instead of having its activity solely 
dependent on the BMP node’s activity (Figure 24). Originally, the Zic1_3 node could only be 
activated if SMAD was turned OFF by BMP and ERK was ON.  
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Figure 24. Functional change of the Zic1_3 gate. 
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0	 0	 0	
0	 1	 1	
1	 0	 0	
1	 1	 0	
Modified	Zic1_3	Gate	
Zic1_3	 SMAD	 ERK	 Zic1_3	
0	 0	 0	 0	
0	 0	 1	 1	
0	 1	 0	 0	
0	 1	 1	 0	
1	 0	 0	 1	
1	 0	 1	 1	
1	 1	 0	 1	
1	 1	 1	 1	
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Figure 25. Attractor states of a healthy naïve ESC after adjustment of the Zic1_3 gate. The attractor states were 
determined by extensive sampling of cell phenotypes based on twenty-four possible combinations of inputs: absence 
or presence of BMP, absence or presence of LIF, absence or presence of 2i, and three levels of growth factor input. 
 
 In this new model we were able to show Naïve ESC’s in cell cycle, neuroectodermal cells 
in cell cycle, dead cells, and Differentiated ESC/Ectodermal ESC/Naïve ESC in G0 states. In the 
BMP OFF condition, dead cells could have occurred in any condition, but they were guaranteed 
to die in the LIF OFF and GF OFF conditions, regardless of 2i expression. Naïve cells were 
produced in the BMP OFF condition in any scenario where LIF was ON, except for the LIF ON, 
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2i OFF, GF_High ON condition, which produced an neuroectodermal cell in cell cycle. In this 
BMP condition, neuroectodermal cells in cell cycle could arise if GF_High was ON and 2i was 
OFF, regardless of LIF expression. Lastly, Differentiated ESC/Ectodermal ESC/Naïve ESC in 
G0 states could arise in the BMP OFF condition as long as GF_High or GF was ON and no LIF 
was present.  
 In the BMP ON condition, once again dead states could occur in environmental 
combinatory condition, but occurred mostly in conditions where GF and LIF were absent. In the 
BMP ON condition, only two other phenotypes were present. The first phenotype, Naïve ESC’s 
in cell cycle, could arise as long as LIF was on, regardless of 2i or GF expression. The other 
phenotype was Differentiated ESC/Ectodermal ESC/Naïve ESC in G0 states, which could arise 
in any BMP ON condition where LIF was OFF and some level of GF was present.  
 Then we analyzed how changes in expression between ON and OFF states for each of the 
environmental stimuli could impact the resulting cell phenotype. GF and GF_High changes 
between the BMP ON condition in the new model did not differ from the BMP ON condition in 
the original model. However, there was the presence of changes of GF and GF_High on the cell 
phenotypes in the BMP OFF condition of this model. Additionally, we did find noticeable 
changes between the BMP OFF and BMP ON states when analyzing LIF, 2i, and BMP 
conditions, as illustrated in Figure 26.  
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Figure 26. Unexpected changes in cell phenotypes dependent on presence or absence of specific 
environmental inputs. After extensive sampling, stable phenotypes were analyzed how they changes based on the 
addition or removal of 2i from the environment. Black lines signify BMP changes, blue lines signify LIF changes, 
red lines illustrate 2i changes, and purple lines represent GF_High changes.  
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After analyzing the changes in the original model, we analyzed odd changes in cell phenotypes 
after the new Zic1_3 gate was implemented in the new model. This change in the Zic1_3 gate 
alleviated a few issues viewed in the first model in terms of the differentiated ESC in G0. With 
this change, the ectodermal cell in G0 became a stable phenotype. Therefore, we could model 
that the Ectoderm cell in cell cycle and the ectoderm cell in G0 could toggle back and forth in 
terms of 2i while naïve ESC’s in G0 and differentiated cells in G0 could only differentiate and be 
stuck in the ectoderm cell in cell cycle phenotype. However, we still developed issues with 
transient phenotypic changes involving LIF and GF_High. To account for this unexpected 
change, we looked at was GF_High change in attractor state 101 in Figure 27. 
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Figure 27. Attractor 101 - Phenotypic transitions from a neuroectodermal cell in cell cycle response to 
transient pulses of GF_High. A 30 time step pule of GF_High affecting an ectodermal cell in cell cycle. Orange 
blocks signify activation and blue blocks represent repression. Each column represents a time-point in the 
simulation. 
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exposed to no GF can differentiate into an ectodermal cell in cell cycle if GF_High is added to 
the environment. Once this Naïve ESC in cell cycle commits to this phenotypic change, it cannot 
go back to its initial state. Once the neuroectodermal cell in cell cycle in present, the model 
shows that if GF_High is OFF exhibits that this cell phenotype will revert back to a Naïve ESC 
in cell cycle state, which is not possible. However, if a Naïve ESC in cell cycle in a GF ON 
environment is moved in a GF_High ON environment, the Naïve ESC in cell cycle will become 
an ectodermal cell in cell cycle. This change comes as a result of manipulation of the 
pluripotency nodes, not the cell cycle nodes. The cell cycles continuously as soon as it is exposed 
to GF_High ON. However, the pluripotency nodes Oct4 and Nanog are OFF when GF_High is 
present and are ON when GF_High is absent. Sox2 stays ON regardless of GF_High expression. 
In both the BMP OFF and BMP ON conditions, changes in LIF expression presented 
similar yet different results from the original model. The differentiated ESC in G0 and the 
ectoderm cell in G0 could become a Naïve ESC in cell cycle if they were exposed to LIF ON, 
yet, a Naïve ESC in cell cycle could not revert back to either previous state if LIF was removed. 
Interestingly, a Naïve ESC in G0 could become a Naïve ESC in cell cycle if it was in a LIF ON 
environment. Inversely, a Naïve ESC in cell cycle could become a Naïve ESC in G0 if LIF was 
removed. We took a deeper look at this unexpected change using a LIF pulse in attractor state 
62, shown in Figure 28. 
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Figure 28. Attractor 62 - Phenotypic transitions from a neuroectodermal cell in G0 in response to transient 
pulses of LIF. A 30 time step pule of LIF affecting an ectodermal cell in cell cycle. Orange blocks signify activation 
and blue blocks represent repression. Each column represents a time-point in the simulation. 
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same instance happens for the differentiated ESC in G0 in this specific start environment. Once 
the ectodermal cell in G0 becomes a naïve ESC in cell cycle, it is stuck and unable to become an 
ectodermal cell in G0 again. However, the naïve ESC in cell cycle is able to become a naïve ESC 
in G0 if LIF is OFF and the naïve ESC in G0 is able to become a naïve ESC in cell cycle if LIF 
is turned back ON. In the beginning of the time course model the ectodermal cell in G0 is 
exhibited by OFF pluripotency nodes and OFF cell cycle nodes. Once the ectodermal cell in G0 
is placed in a LIF ON environment, the pluripotency nodes and cell cycle nodes turn ON, which 
accurately demonstrated the behavior of a naïve ESC in cell cycle. Once LIF turns back OFF, the 
pluripotency nodes remain ON while the cell cycle nodes turn OFF, illustrating a naïve ESC in 
G0. 
 A similar scenario occurred in the when analyzing changes in 2i in the BMP OFF 
condition. In this condition, if a LIF OFF GF_High ON 2i OFF environment produced an 
ectodermal cell in cell cycle and a LIF OFF GF_High ON 2i ON environment produced a 
Differentiated ESC/ Ectodermal ESC/ Naïve ESC in G0 state. A Differentiated ESC/ Naïve ESC 
in G0 state would become an Ectodermal cell in cell cycle if 2i was removed. The 
neuroectodermal cell in cell cycle is incapable of reverting back to a Differentiated ESC/ Naïve 
ESC in G0 state if 2i is reintroduced. However, the neuroectodermal cells can toggle back and 
forth by being in G0 if 2i is present and in cell cycle if 2i is absent. 
 The last major change between the model with the original Zic1_3 gate and the new 
Zic1_3 gate was illustrated by changes in cell phenotype based on BMP expression. If BMP was 
OFF, an ectodermal cell in cell cycle would arise in the GF_High 2i OFF LIF OFF environment. 
In that same condition, if BMP was on a Differentiated ESC/ Ectodermal ESC/ Naïve ESC in G0 
phenotype would arise. If BMP was removed from the Differentiated ESC/ Ectodermal ESC/ 
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Naïve ESC in G0 state in G0 phenotype, the cell would differentiate into a neuroectodermal cell 
in cell cycle, but the ectodermal cell in cell cycle could not revert back to the Differentiated ESC/ 
Naïve ESC in G0 phenotypes if BMP once again became present. However, if BMP was turned 
back ON in a neuroectodermal cell in cell cycle, it could revert back to an ectodermal cell in G0 
phenotype.  
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DISCUSSION 
This model exhibits an array of distinct, yet connected, phenotypes of neural as well as 
embryonic stem cells. Our model produced an array of information regarding phenotypic 
transitions triggered by changes in the cellular environment, some of which turned out to be 
somewhat unexpected. These unexpected phenotypic changes point to flaws or unexplored 
boundaries in our current understanding of the biology of neuronal specification. This model is 
the first stride in an effort to understanding how early specific cell types in the neuronal lineage 
can change their molecular and phenotypic behavior, as various signaling pathways and 
transcription factors contributing to proliferation and differentiation converge on them.  
 
Modeling proliferation and differentiation of neurodevelopmental phenotypes 
To test our model, we established a stable embryonic stem cell state to serve as the base 
phenotype for further experimentation. This ESC model was the sampled to produce an array of 
phenotypic attractor states of neurodevelopmental phenotypes (ESC, Differentiated, 
neuroectoderm), as well as distinct cell cycle behaviors (G0 or Cell Cycle) in different 
combinations of environmental inputs (BMP, LIF, GF, 2i). The model produced phenotypes that 
were consistent with our expectations from the experimental literature. When looking at the 
responses of these phenotypes to environmental change, however, there were a few interesting 
cases where the model was unable to correctly match the way certain cells differentiated, and 
locked into their final state. At the molecular level, the main root of these interesting 
differentiative anomalies is the lack of a locking mechanism/pathway that would prevent a 
differentiated cell from becoming either naïve or less differentiated in the presence of LIF and/or 
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2i. This lack reflects our inability to finds any hint of these molecular mechanisms in the 
literature.  
We were able to produce these findings by looking at surprising connections across 
phenotypic changes, based on a manipulating the presence or absence of a single environmental 
stimulus. Taking a closer look at the time course of molecular changes produced by transient 
pulses of environmental input signals, we were able to understand the precise signal propagation 
by which phenotype changes occur in our model. We mainly looked at markers that are involved 
in pluripotency and the cell cycle. Here we were able to determine whether the cell was in a 
naïve or differentiated state, as well as whether it was in G0 or undergoing a cell cycle.   
 Using our model, we were also able to determine general rules or characteristics of each 
input stimulus’s impact on a cell’s molecular and phenotypic expression. For example, if growth 
factor was absent, the cell can only live if LIF is present, (which is consistent with known ESC 
biology). In these cases, the cell remains naïve regardless of 2i or BMP expression. However, 
although these ESCs were unable to become a terminally differentiated with no way back to the 
ESC state, they were able to undergo cell cycle as expected. Therefore, we could determine that 
the presence of growth factors has a prominent role in cell type determination, due to the fact that 
ESCs could only differentiate if mitogens were present to activate ERK signaling.  
 Furthermore, using only the known molecular connections leading to Zic1/3 activation 
(i.e., the original Zic1_3 gate), we were able to reproduce the fact that a self-renewing 
neuroectoderm (i.e., in cell cycle) was only able to arise in the NO BMP environment. In order 
for this to happen, GF_High needed to be ON and 2i needed to be OFF (LIF’s expression was 
inconsequential). In the BMP ON environment, the cell could not phenotypically become 
anything more than a differentiated cell in G0. In both models, BMP needs to be absent for initial 
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entry kick into the neuroectodermal lineage. If BMP is present, only transitions of the naïve state 
or differentiation to a cell phenotype in G0 can happen. Moreover, GF_High needs to be present 
for transitions into the neuroectodermal phenotype to occur. When the Zic1_3 gate was a 
modified to sustain its own activity, the neuroectodermal cells in G0 could additionally be 
modeled, but only LIF and 2i were absent. This was due to the fact that we are still missing 
critical links that turn the ESC core circuitry off in the presence of neuronal lineage factors. 
In order to further comprehend these intriguing phenotype changes, I propose a further 
series in silico analyses. I propose expanding the model and incorporating more nodes and 
mechanisms to further understand the pathways and environmental stimuli present, in order to 
obtain a more comprehensive molecular model of the phenotypes of interest.  I predict that two 
critical links must be present to create more specific cell phenotypes, links we could not find in 
current literature. First, it would be beneficial to determine the mechanisms that sustain Zic1/3 
expression in the presence of BMP at later points in development. Second, it would be important 
to determine what locks off the ESC pluripotency circuit, preventing its reactivation in ESC 
medium (i.e., LIF and 2i). 
 
A modular approach to modeling embryonic stem cell intracellular regulation 
The model was able to exhibit and synthesize previously established phenotypic and 
molecular characteristics of the early, cellular stages of neurodevelopment. As were modeling 
Naïve ESC’s, differentiated cells and neuroectodermal cells in either G0 or in a cell cycle (or 
dead), it was intriguing to see how coordinated phenotypic changes could arise based on the 
manipulation of a single environment. Using the 4D graph analyses of each individual input’s 
effect, we were able to see how the phenotypes are synergistically connected. Using the time 
course analyses, we could visually follow the molecular changes that occur within each module 
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of the network, giving rise to these phenotypic changes. Using these two types of analysis, we 
were able to categorize the model’s time-dependent predictions in terms of cell type, cell 
cycle/G0 state, or apoptosis.  
 
Weaknesses of the current ESC neuro-differentiation model 
 Before our model is ready to aid experimental research, some of its weaknesses need to 
be addressed. First, my model is completely unable to lock a neuroectodermal cell into its 
differentiated state. This was evident as the neuroectodermal cell phenotypes were able to revert 
back to naïve, or generic differentiated states. A cellular locking loop/mechanism to prevent 
phenotypic movement back to these previous states is sorely needed, but not covered by current 
literature. The inclusion of self-sustaining lineage specific factors could serve as a mechanism to 
prevent a phenotype from reverting back to a less differentiated state, as observed in a model 
studying differentiated endoderm and trophectoderm cells (Auerbach, 2017). Ideally, the 
pluripotency circuit should never be completely activated past the Naïve ESC state. The cell 
cycle circuit can remain engaged as the cell moves forward in its development towards a fully 
mature neuron, but the full pluripotency network should never be on again.  
 It is important to acknowledge that some of these issues are not due to flaws in the 
construction of the model. The literature regarding this locking mechanism is nonexistent. In 
vitro, experiments have been conducted where a differentiated cell could be forced to revert to 
previous cell types through the application of reprogramming transcription factors (Takahashi & 
Yamanaka, 2006), but there isn’t a clear idea as to why, exactly, these cell don’t revert back to a 
previous state in the first place.  
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Lastly, it is difficult to distinguish the precise signals that specify non-neural ectoderm 
vs. the neuroectoderm. We know that the ectoderm arises in the presence of BMP, and soon 
thereafter the neuroectoderm arises in its absence (Figure 6). In this model, we assumed that the 
neuroectoderm could be triggered from ESCs by the absence of BMP signaling, together with a 
loss of pluripotency-maintaining signals (LIF and 2i). In reality, there must be other factors 
present that further distinguish, and separately lock in these two cell lineages.  
 
Future directions 
Due to the unknowns detailed above, building on our current model to accurately 
reproduce other neural lineages such as neural crest cells is a considerable challenge. That said, 
expanding the model to include other neurodevelopmental signaling pathways such as Notch and 
Sonic Hedgehog (SHH) signaling could lead to a more comprehensive description of neuro-
differentiation and provide the ability to model more cell types. Once the model is expanded (and 
its inability to maintain differentiation has been overcome), in vitro studies could be designed to 
track cellular responses to some of the transient stimuli where the model predicts irreversible 
phenotype changes. 
In conclusion, Boolean modeling is a great instrument for testing assumptions about 
molecular and environmental changes, in terms of their ability to generate robust phenotypes and 
cell state transitions. It is also powerful for starkly exposing gaps in our current knowledge, 
especially regarding synergies between environmental inputs. In our case, the lack of lock-in 
mechanisms that keeps neuroectodermal cell from undifferentiating was a real surprise. It stands 
in sharp contrast with our knowledge of the mechanisms that lock endodermal or trophoblast 
cells into their final state (the subject of an Independent Study thesis by Micah Auerbach, 2017). 
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Moving forward, Boolean modeling lays the groundwork for future in silico models, and 
analyses leading to better integration between in silico and wet lab research. Furthermore it can 
push boundaries of current understanding and eventually help unearth non-intuitive behavior 
cells undergo through development. 	
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SUPPLEMENTARY INFORMATION 
Supplementary Table S1. Cell Growth Links 
Node Logic Gate Link Reference 
AKT PDK1 AND PIP3 
PIP3 →  Lawlor, M. A., and 
Alessi, D. R. (2001) 
PKB/Akt. Journal of 
Cell Science 114, 
2903–2910.  
PDK1 →  
BRAF Ras Ras →  
Johnson, G. L., and 
Lapadat, R. (2002) 
Mitogen-Activated 
Protein Kinase 
Pathways Mediated 
by ERK, JNK, and 
p38 Protein Kinases. 
Science 298, 1911– 
1912.  
eIF4E mTORC1 mTORC1 → 
Gingras, A.-C., 
Gygi, S. P., Raught, 
B., Polakiewicz, R. 
D., Abraham, R. T., 
Hoekstra, M. F., 
Aebersold, R., and 
Sonenberg, N. 
(1999) Regulation 
of 4E-BP1 
phosphorylation: a 
novel two-step 
mechanism. Genes 
Dev. 13, 1422–
1437.  						
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ERK MEK AND NOT 
BMP 
BMP –| 
         Zhang, J., & Li, L. 
(2005). BMP 
signaling and stem 
cell regulation. 
Developmental 
Biology, 284(1), 1–
11.  
MEK →  
Johnson, G. L., and 
Lapadat, R. (2002) 
Mitogen-Activated 
Protein Kinase 
Pathways Mediated 
by ERK, JNK, and 
p38 Protein Kinases. 
Science 298, 1911– 
1912.  
GF_High GF_High GF_High →  N/A 
GF GF OR GF_High 
GF_High →  N/A 
GF →  N/A 
Grb2 GF_High AND 
RTK 
GF_High →  
Saito, Y., Furukawa, 
T., Arano, Y., 
Fujibayashi, Y., and 
Saga, T. (2010) 
Basic study on SH2 
domain of Grb2 as a 
molecular probe for 
detection of RTK 
activation. Int. J. 
Oncol. 37, 281–287.  
RTK →  
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GSK3 NOT AKT AND 
NOT Two_i 
Two_i –| 
Shimizu, T., Ueda, 
J., Ho, J. C., 
Iwasaki, K., 
Poellinger, L., 
Harada, I., & 
Sawada, Y. (2012). 
Dual inhibition of 
Src and GSK3 
maintains mouse 
embryonic stem 
cells, whose 
differentiation is 
mechanically 
regulated by Src 
signaling. Stem 
Cells (Dayton, 
Ohio), 30(7), 1394–
1404.  
AKT –| 
Cross, D. A. E., 
Alessi, D. R., 
Cohen, P., 
Andjelkovich, M., 
and Hemmings, B. 
A. (1995) Inhibition 
of glycogen 
synthase kinase-3 
by insulin mediated 
by protein kinase B. 
Nature 378, 785–
789.  
MEK BRAF AND NOT 
Two_i 
Two_i –| 
Silva, J., Barrandon, 
O., Nichols, J., 
Kawaguchi, J., 
Theunissen, T. W., 
& Smith, A. (2008). 
Promotion of 
Reprogramming to 
Ground State 
Pluripotency by 
Signal Inhibition. 
PLOS Biology, 
6(10), 253.  	
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BRAF →  
Johnson, G. L., and 
Lapadat, R. (2002) 
Mitogen-Activated 
Protein Kinase 
Pathways Mediated 
by ERK, JNK, and 
p38 Protein Kinases. 
Science 298, 1911– 
1912.  
mTORC1 
(AKT OR E2F1) 
AND (AKT OR 
ERK) AND (E2F1 
OR ERK) 
ERK →  
Mendoza, M. C., Er, 
E. E., and Blenis, J. 
(2011) The Ras-
ERK and PI3K-
mTOR Pathways: 
Cross-talk and 
Compensation. 
Trends Biochem Sci 
36, 320–328.  
E2F1 →  
Real, S., Meo-Evoli, 
N., Espada, L., and 
Tauler, A. (2011) 
E2F1 Regulates 
Cellular Growth by 
mTORC1 Signaling. 
PLOS ONE 6, 
e16163.  
AKT →  
Hahn-Windgassen, 
A., Nogueira, V., 
Chen, C.-C., Skeen, 
J. E., Sonenberg, N., 
and Hay, N. (2005) 
Akt Activates the 
Mammalian Target 
of Rapamycin by 
Regulating Cellular 
ATP Level and 
AMPK Activity. J. 
Biol. Chem. 280, 
32081– 32089.  
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PDK1 PIP3 PIP3 →  
Vivanco, I., and 
Sawyers, C. L. 
(2002) The 
phosphatidylinositol 
3- Kinase–AKT 
pathway in human 
cancer. Nat Rev 
Cancer 2, 489– 501.  
PI3K LIFR OR RTK OR 
Ras 
LIFR →  
Ohtsuka, S., Nakai-
Futatsugi, Y., & 
Niwa, H. (2015). 
LIF signal in mouse 
embryonic stem 
cells. JAK-STAT, 
4(2).  
Ras →  
Castellano, E., and 
Downward, J. 
(2010) Role of RAS 
in the regulation of 
PI 3- kinase. Curr. 
Top. Microbiol. 
Immunol. 346, 143–
169.  
RTK →  
Domchek, S. M., 
Auger, K. R., 
Chatterjee, S., 
Burke, T. R., and 
Shoelson, S. E. 
(1992) Inhibition of 
SH2 
domain/phosphoprot
ein association by a 
nonhydrolyzable 
phosphonopeptide. 
Biochemistry 31, 
9865–9870.  				
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PIP3 PI3K PI3K →  
Cantley, L. C. (2002) 
The 
phosphoinositide 3-
kinase pathway. 
Science 296, 1655– 
1657.  
Ras Grb2 OR SOS 
Grb2 →  
Margolis, B., and 
Skolnik, E. Y. 
(1994) Activation of 
Ras by receptor 
tyrosine kinases. J. 
Am. Soc. Nephrol. 5, 
1288– 1299.  
SOS →  
RTK GF OR GF_High 
GF_High →  
Hubbard, S. R., and 
Miller, W. T. (2007) 
Receptor tyrosine 
kinases: mechanisms 
of activation and 
signaling. Curr Opin 
Cell Biol 19, 117–
123. 
GF →  
SOS Grb2 Grb2 →  
Simon, J. A., and 
Schreiber, S. L. 
(1995) Grb2 SH3 
binding to peptides 
from Sos: evaluation 
of a general model 
for SH3-ligand 
interactions. Chem. 
Biol. 2, 53–60.  	
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Supplementary Table S2. Cell Cycle Links 
Node Logic Gate Link Reference 
4N_DNA 
NOT Cdh1 AND 
(4N_DNA OR 
CyclinA) AND 
(4N_DNA OR 
Replication) 
4N_DNA →  N/A 
Cdh1 –| 
Qiao, X., Zhang, L., 
Gamper, A. M., 
Fujita, T., and Wan, 
Y. (2010) APC/C- 
Cdh1: from cell cycle 
to cellular 
differentiation and 
genomic integrity. 
Cell Cycle 9, 3904– 
3912.  
CyclinA →  
Katsuno, Y., Suzuki, 
A., Sugimura, K., 
Okumura, K., 
Zineldeen, D. H., 
Shimada, M., Niida, 
H., Mizuno, T., 
Hanaoka, F., and 
Nakanishi, M. (2009) 
Cyclin A-Cdk1 
regulates the origin 
firing program in 
mammalian cells. 
Proc. Natl. Acad. Sci. 
U.S.A. 106, 3184– 
3189.  
Replication →  N/A 								
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Cdc20 NOT Cdh1 AND NOT Mad2 AND 
pAPC 
pAPC →  
Manchado, E., 
Eguren, M., and 
Malumbres, M. 
(2010) The anaphase- 
promoting 
complex/cyclosome 
(APC/C): cell-cycle- 
dependent and - 
independent 
functions. Biochem. 
Soc. Trans. 38, 65– 
71.  
Cdh1 –| 
Mad2 –| 
Reddy, S. K., Rape, 
M., Margansky, W. 
A., and Kirschner, M. 
W. (2007) 
Ubiquitination by the 
anaphase-promoting 
complex drives 
spindle checkpoint 
inactivation. Nature 
446, 921–925.  
Cdc25A 
(CyclinA OR 
CyclinE) AND 
(CyclinA OR 
E2F1) AND 
(CyclinE OR E2F1) 
AND (E2F1 OR 
NOT Cdh1) 
CyclinA →  
Frazer, C., and 
Young, P. G. (2012) 
Phosphorylation 
Mediated Regulation 
of Cdc25 Activity, 
Localization and 
Stability, in Protein 
Phosphorylation in 
Human Health 
(Huang, C., Ed.). 
InTech.  
CyclinE →  
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E2F1 → 
Vigo, E., Müller, H., 
Prosperini, E., 
Hateboer, G., 
Cartwright, P., 
Moroni, M. C., and 
Helin, K. (1999) 
CDC25A phosphatase 
is a target of E2F and 
is required for 
efficient E2F-induced 
S phase. Mol. Cell. 
Biol. 19, 6379–6395.  
Cdh1 –| 
Donzelli, M., 
Squatrito, M., 
Ganoth, D., Hershko, 
A., Pagano, M., and 
Draetta, G. F. (2002) 
Dual mode of 
degradation of Cdc25 
A phosphatase. 
EMBO J 21, 4875–
4884.  
Cdc25C 
(Cdk1 OR 
CyclinA) AND 
(CyclinA OR 
CyclinB) 
CyclinA →  
Karaïskou, A., Cayla, 
X., Haccard, O., 
Jessus, C., and Ozon, 
R. (1998) MPF 
amplification in 
Xenopus oocyte 
extracts depends on a 
two-step activation of 
cdc25 phosphatase. 
Exp. Cell Res. 244, 
491–500.  
Cdk1 →  
CyclinB →  
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Cdh1 
NOT CyclinA 
AND (NOT Cdk1 
OR NOT CyclinB) 
AND pAPC 
pAPC →  
Sudo, T., Ota, Y., 
Kotani, S., Nakao, 
M., Takami, Y., 
Takeda, S., & Saya, 
H. (2001). Activation 
of Cdh1-dependent 
APC is required for 
G1 cell cycle arrest 
and DNA damage-
induced G2 
checkpoint in 
vertebrate cells. The 
EMBO Journal, 
20(22), 6499–6508.  
CyclinA –| Harper, J. W., Burton, 
J. L., and Solomon, 
M. J. (2002) The 
anaphase- promoting 
complex: it’s not just 
for mitosis any more. 
Genes Dev. 16, 2179–
2206.  
CyclinB –| 
Cdk1 –| 
Cdk1 
(Cdc25C OR Cdk1) 
AND (Cdc25C OR 
CyclinA) AND 
(Cdc25C OR 
CyclinB) AND 
(Cdc25C OR NOT 
Wee1) AND (Cdk1 
OR NOT Wee1) 
AND (CyclinA OR 
CyclinB) 
Wee1 –| 
Heald, R., 
McLoughlin, M., and 
McKeon, F. (1993) 
Human wee1 
maintains mitotic 
timing by protecting 
the nucleus from 
cytoplasmically 
activated cdc2 kinase. 
Cell 74, 463–474.  
Cdk1 →  N/A 
Cdc25C → Jackman, M. R., and 
Pines, J. N. (1997) 
Cyclins and the G2/M 
transition. Cancer 
Surv. 29, 47– 73.  
CyclinA →  
CyclinB →  		
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CyclinA 
NOT pAPC AND 
(Cdc25A OR 
CyclinA) AND 
(Cdc25A OR E2F1 
OR NOT pRB) 
AND (CyclinA OR 
E2F1) AND (NOT 
Cdh1 OR NOT 
UbcH10) 
pRB –| 
Kitagawa, M., 
Higashi, H., 
Takahashi, I. S., 
Okabe, T., Ogino, H., 
Taya, Y., … 
Okuyama, A. (1994). 
A cyclin-dependent 
kinase inhibitor, 
butyrolactone I, 
inhibits 
phosphorylation of 
RB protein and cell 
cycle progression. 
Oncogene, 9(9), 
2549–2557. 
E2F1 →  
DeGregori, J., 
Kowalik, T., & 
Nevins, J. R. (1995). 
Cellular targets for 
activation by the 
E2F1 transcription 
factor include DNA 
synthesis- and G1/S-
regulatory genes. 
Molecular and 
Cellular Biology, 
15(8), 4215–4224. 
Cdc25A →  
Katsuno, Y., Suzuki, 
A., Sugimura, K., 
Okumura, K., 
Zineldeen, D. H., 
Shimada, M., Niida, 
H., Mizuno, T., 
Hanaoka, F., and 
Nakanishi, M. (2009) 
Cyclin A-Cdk1 
regulates the origin 
firing program in 
mammalian cells. 
Proc. Natl. Acad. Sci. 
U.S.A. 106, 3184– 
3189.  	
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  CyclinA →  N/A 
pAPC –| 
Yam, C. H., Fung, T. 
K., and Poon, R. Y. 
C. (2002) Cyclin A in 
cell cycle control and 
cancer. Cell. Mol. 
Life Sci. 59, 1317– 
1326.  
Cdh1 –| 
Rape, M., and 
Kirschner, M. W. 
(2004) Autonomous 
regulation of the 
anaphase-promoting 
complex couples 
mitosis to S-phase 
entry. Nature 432, 
588–595.  
UbcH10 –| 
CyclinB 
NOT Cdh1 AND 
(Cdk1 OR 
CyclinA) AND 
(CyclinA OR 
CyclinB) AND 
(NOT Cdc20 OR 
NOT pAPC) 
Cdk1 →  
Mitra, J., & Enders, 
G. H. (2004). Cyclin 
A/Cdk2 complexes 
regulate activation of 
Cdk1 and Cdc25 
phosphatases in 
human cells. 
Oncogene, 23(19), 
3361–3367.  
CyclinB →  N/A 
CyclinA →  
De Boer, L., Oakes, 
V., Beamish, H., 
Giles, N., Stevens, F., 
Somodevilla-Torres, 
M., … Gabrielli, B. 
(2008). Cyclin 
A/cdk2 coordinates 
centrosomal and 
nuclear mitotic 
events. Oncogene, 
27(31), 4261–4268.  			
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  pAPC –| Harper, J. W., Burton, 
J. L., and Solomon, 
M. J. (2002) The 
anaphase- promoting 
complex: it’s not just 
for mitosis any more. 
Genes Dev. 16, 2179–
2206.  
Cdc20 –| 
Cdh1 –| 
CyclinD1 
NOT CAD AND 
NOT Replication 
AND  (CyclinD1 
OR E2F1 OR NOT 
GSK3) AND 
(CyclinD1 OR Myc 
OR NOT GSK3) 
AND (CyclinD1 
OR NOT p21 OR  
NOT pRB) AND 
(E2F1 OR Myc) 
AND (E2F1 OR 
NOT p21) AND 
(Myc OR NOT 
p21) AND (NOT 
GSK3 OR NOT 
p21) 
CAD –| N/A 
Replication –| 
Stacey, D. W. (2003) 
Cyclin D1 serves as a 
cell cycle regulatory 
switch in actively 
proliferating cells. 
Curr. Opin. Cell Biol. 
15, 158–163.  
CyclinD1 →  N/A 
p21 –| 
Harper, J. W., 
Elledge, S. J., 
Keyomarsi, K., 
Dynlacht, B., Tsai, L. 
H., Zhang, P., 
Dobrowolski, S., Bai, 
C., Connell-Crowley, 
L., and Swindell, E. 
(1995) Inhibition of 
cyclin-dependent 
kinases by p21. Mol. 
Biol. Cell 6, 387– 
400.  			
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GSK3 –| 
Yang, K., Guo, Y., 
Stacey, W. C., 
Harwalkar, J., 
Fretthold, J., Hitomi, 
M., & Stacey, D. W. 
(2006). Glycogen 
synthase kinase 3 has 
a limited role in cell 
cycle regulation of 
cyclin D1 levels. 
BMC Cell Biology, 7, 
33.  
pRB –| 
Connell-Crowley, L., 
Harper, J. W., and 
Goodrich, D. W. 
(1997) Cyclin 
D1/Cdk4 regulates 
retinoblastoma 
protein-mediated cell 
cycle arrest by site- 
specific 
phosphorylation. Mol. 
Biol. Cell 8, 287–301.  
E2F1 →  
Fan, J., and Bertino, 
J. R. (1997) 
Functional roles of 
E2F in cell cycle 
regulation. Oncogene 
14, 1191–1200.  													
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Myc →  
Daksis, J. I., Lu, R. 
Y., Facchini, L. M., 
Marhin, W. W., and 
Penn, L. J. (1994) 
Myc induces cyclin 
D1 expression in the 
absence of de novo 
protein synthesis and 
links mitogen- 
stimulated signal 
transduction to the 
cell cycle. Oncogene 
9, 3635–3645.  
CyclinE 
E2F1 AND NOT 
CAD AND NOT 
p27Kip1 AND 
NOT pRB AND 
(Cdh1 OR NOT 
Metaphase) 
CAD –| N/A 
Cdh1 → 
Qiao, X., Zhang, L., 
Gamper, A. M., 
Fujita, T., and Wan, 
Y. (2010) APC/C- 
Cdh1: from cell cycle 
to cellular 
differentiation and 
genomic integrity. 
Cell Cycle 9, 3904– 
3912.  
Metaphase –| N/A 
P27Kip1 –| 
Coqueret, O. (2003) 
New roles for p21 and 
p27 cell-cycle 
inhibitors: a function 
for each cell 
compartment? Trends 
Cell Biol. 13, 65–70.  					
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pRB –| 
(1) Helin, K. (1998) 
Regulation of cell 
proliferation by the 
E2F transcription 
factors. Curr. Opin. 
Genet. Dev. 8, 28–35.  
E2F1 →  
Ohtani, K., 
DeGregori, J., and 
Nevins, J. R. (1995) 
Regulation of the 
cyclin E gene by 
transcription factor 
E2F1. Proc. Natl. 
Acad. Sci. U.S.A. 92, 
12146–12150.  
E2F1 
NOT CyclinA 
AND NOT pRB 
AND (E2F1 OR 
Myc) 
CyclinA –| 
Krek, W., Ewen, M. 
E., Shirodkar, S., 
Arany, Z., Kaelin, W. 
G., and Livingston, 
D. M. (1994) 
Negative regulation 
of the growth- 
promoting 
transcription factor 
E2F-1 by a stably 
bound cyclin A- 
dependent protein 
kinase. Cell 78, 161– 
172.  
E2F1 →  N/A 									
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  Myc –| Dong, P., Maddali, 
M. V., Srimani, J. K., 
Thélot, F., Nevins, J. 
R., Mathey-Prevot, 
B., and You, L. 
(2014) Division of 
labour between Myc 
and G1 cyclins in cell 
cycle commitment 
and pace control. Nat 
Commun 5, 4750.  
pRB –| 
Mad2 
4N_DNA AND 
Cdk1 AND 
CyclinB AND 
NOT Metaphase 
AND (NOT Cdc20 
|OR NOT pAPC) 
4N_DNA →  
Magiera, M. M., 
Gueydon, E., and 
Schwob, E. (2014) 
DNA replication and 
spindle checkpoints 
cooperate during S 
phase to delay mitosis 
and preserve genome 
integrity. J Cell Biol 
204, 165– 175.  
Metaphase –| 
Reddy, S. K., Rape, 
M., Margansky, W. 
A., and Kirschner, M. 
W. (2007) 
Ubiquitination by the 
anaphase-promoting 
complex drives 
spindle checkpoint 
inactivation. Nature 
446, 921–925.  
pAPC –| 
Cdc20 –| 
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Cdk1 →  
Chen, R. H., Waters, 
J. C., Salmon, E. D., 
and Murray, A. W. 
(1996) Association of 
spindle assembly 
checkpoint 
component XMAD2 
with unattached 
kinetochores. Science 
274, 242–246.  
CyclinB →  
Metaphase 
4N_DNA AND 
Cdk1 AND 
CyclinB AND 
(NOT Cdc20 OR 
NOT pAPC) 
pAPC –| N/A 
4N_DNA → Nezi, L., and 
Musacchio, A. (2009) 
Sister chromatid 
tension and the 
spindle assembly 
checkpoint. Current 
Opinion in Cell 
Biology 21, 785–795.  
Cdc20 –| 
Cdk1 →  
CyclinB →  
Myc 
(E2F1 OR ERK OR 
Klf4) AND (ERK 
OR Klf4 OR Myc 
|OR eIF4E) 
AKT →  
Zhu, J., Blenis, J., and 
Yuan, J. (2008) 
Activation of 
PI3K/Akt and MAPK 
pathways regulates 
Myc-mediated 
transcription by 
phosphorylating and 
promoting the 
degradation of Mad1. 
Proc. Natl. Acad. Sci. 
U.S.A. 105, 6584– 
6589.  
ERK →  
Myc →  N/A 					
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eIF4E →  
Lin, C.-J., Malina, A., 
and Pelletier, J. 
(2009) c-Myc and 
eIF4F Constitute a 
Feedforward Loop 
That Regulates Cell 
Growth: Implications 
for Anticancer 
Therapy. Cancer Res 
69, 7491–7494. 
Klf4 →  
Schmidt, R., & Plath, 
K. (2012). The roles 
of the reprogramming 
factors Oct4, Sox2 
and Klf4 in resetting 
the somatic cell 
epigenome during 
induced pluripotent 
stem cell generation. 
Genome Biology, 13, 
251.  
E2F1 →  
Oswald, F., Lovec, 
H., Möröy, T., and 
Lipp, M. (1994) E2F- 
dependent regulation 
of human MYC: 
trans-activation by 
cyclins D1 and A 
overrides tumour 
suppressor protein 
functions. Oncogene 
9, 2029–2036.  
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p21_mRNA NOT Myc Myc –| 
Mitchell, K. O., and 
El-Deiry, W. S. 
(1999) 
Overexpression of c- 
Myc inhibits p21W 
AF1/CIP1 expression 
and induces S-phase 
entry in 12-O- 
tetradecanoylphorbol- 
13-acetate (TPA)- 
sensitive human 
cancer cells. Cell 
Growth Differ. 10, 
223–230.  
p21 
NOT CyclinE AND 
(NOT Cdc25A OR 
NOT CyclinA) 
AND p21_mRNA 
p21_mRNA →  
Butz, K., Geisen, C., 
Ullmann, A., 
Zentgraf, H., & 
Hoppe-Seyler, F. 
(1998). Uncoupling 
of 
p21WAF1/CIP1/SDI1 
mRNA and protein 
expression upon 
genotoxic stress. 
Oncogene, 17(6), 
781. 
Cdc25A –| 
Saha, P., Eichbaum, 
Q., Silberman, E. D., 
Mayer, B. J., and 
Dutta, A. (1997) 
p21CIP1 and 
Cdc25A: competition 
between an inhibitor 
and an activator of 
cyclin-dependent 
kinases. Mol. Cell. 
Biol. 17, 4338–4345.  				
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CyclinA –| 
Harper, J. W., 
Elledge, S. J., 
Keyomarsi, K., 
Dynlacht, B., Tsai, L. 
H., Zhang, P., 
Dobrowolski, S., Bai, 
C., Connell-Crowley, 
L., and Swindell, E. 
(1995) Inhibition of 
cyclin-dependent 
kinases by p21. Mol. 
Biol. Cell 6, 387– 
400.  
CyclinE –| 
p27Kip1 
NOT CyclinD1 
AND (NOT Cdk1 
OR NOT CyclinB) 
AND (NOT 
CyclinA OR NOT 
CyclinE) 
CyclinA –| Montagnoli, A., 
Fiore, F., Eytan, E., 
Carrano, A. C., 
Draetta, G. F., 
Hershko, A., and 
Pagano, M. (1999) 
Ubiquitination of p27 
is regulated by Cdk- 
dependent 
phosphorylation and 
trimeric complex 
formation. Genes Dev 
13, 1181–1189.  
Cdk1 –| 
CyclinB –| 
CyclinD1 –| 
CyclinE –| 
pAPC 
(Cdc20 OR Cdk1) 
AND (Cdc20 OR 
CyclinB) AND 
(Cdk1 OR pAPC) 
AND (CyclinB OR 
pAPC) 
pAPC →  Qiao, X., Zhang, L., 
Gamper, A. M., 
Fujita, T., and Wan, 
Y. (2010) APC/C- 
Cdh1: from cell cycle 
to cellular 
differentiation and 
genomic integrity. 
Cell Cycle 9, 3904– 
3912.  
Cdc20 →  
Cdk1 →  
CyclinB →  
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pRB 
NOT CyclinD1 
AND (NOT Cdk1 
OR NOT CyclinB) 
AND (NOT 
CyclinA OR 
p27Kip1) AND 
(NOT CyclinE OR 
p27Kip1) 
CyclinA –| Hofmann, F., and 
Livingston, D. M. 
(1996) Differential 
effects of cdk2 and 
cdk3 on the control of 
pRb and E2F function 
during G1 exit. Genes 
Dev. 10, 851–861.  
Cdk1 –| 
CyclinB –| 
CyclinD1 –| 
Kato, J., Matsushime, 
H., Hiebert, S. W., 
Ewen, M. E., and 
Sherr, C. J. (1993) 
Direct binding of 
cyclin D to the 
retinoblastoma gene 
product (pRb) and 
pRb phosphorylation 
by the cyclin D- 
dependent kinase 
CDK4. Genes Dev. 7, 
331–342. 
CyclinE –| 
Novák, B., and 
Tyson, J. J. (2004) A 
model for restriction 
point control of the 
mammalian cell 
cycle. J. Theor. Biol. 
230, 563–579.  
p27Kip1 →  
Coqueret, O. (2003) 
New roles for p21 and 
p27 cell-cycle 
inhibitors: a function 
for each cell 
compartment? Trends 
Cell Biol. 13, 65–70.  				
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Replication 
NOT 4N_DNA 
AND NOT CAD 
AND (Cdc25A OR 
CyclinE OR E2F1) 
AND (Cdc25A OR 
Replication) AND 
(CyclinE OR 
Replication) AND 
(E2F1 OR 
Replication) 
CAD –| 
Enari, M., Sakahira, 
H., Yokoyama, H., 
Okawa, K., Iwamatsu, 
A., and Nagata, S. 
(1998) A caspase-
activated DNase that 
degrades DNA during 
apoptosis, and its 
inhibitor ICAD. 
Nature 391, 43–50.  
4N_RNA –| N/A 
Replication →  N/A 
E2F1 →  
Li, F. X., Zhu, J. W., 
Hogan, C. J., and 
DeGregori, J. (2003) 
Defective gene 
expression, S phase 
progression, and 
maturation during 
hematopoiesis in 
E2F1/E2F2 mutant 
mice. Mol. Cell. Biol. 
23, 3607–3622.  
CyclinE →  
Coverley, D., Laman, 
H., and Laskey, R. A. 
(2002) Distinct roles 
for cyclins E and A 
during DNA 
replication complex 
assembly and 
activation. Nat. Cell 
Biol. 4, 523–528.  
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Cdc25A →  
Mailand, N., Falck, J., 
Lukas, C., Syljuâsen, 
R. G., Welcker, M., 
Bartek, J., and Lukas, 
J. (2000) Rapid 
destruction of human 
Cdc25A in response 
to DNA damage. 
Science 288, 1425– 
1429.  
UbcH10 
(Cdc20 OR 
CyclinA OR 
CyclinB OR NOT 
Cdh1) AND (NOT 
Cdh1 OR UbcH10) 
Cdh1 –| Rape, M., and 
Kirschner, M. W. 
(2004) Autonomous 
regulation of the 
anaphase-promoting 
complex couples 
mitosis to S-phase 
entry. Nature 432, 
588–595.  
Cdc20 →  
UbcH10 →  
CyclinA →  
CyclinB →  
Wee1 
(CAD OR NOT 
Cdk1 OR NOT 
CyclinA) AND 
(CAD OR NOT 
Cdk1OR NOT 
CyclinB) AND 
(CAD OR 
Replication) 
CAD →  
Domínguez-Kelly, R., 
Martín, Y., 
Koundrioukoff, S., 
Tanenbaum, M. E., 
Smits, V. A. J., 
Medema, R. H., 
Debatisse, M., and 
Freire, R. (2011) 
Wee1 controls 
genomic stability 
during replication by 
regulating the Mus81-
Eme1 endonuclease. J 
Cell Biol 194, 567–
579.  
Replication →  
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  Cdk1 –| Deibler, R. W., and 
Kirschner, M. W. 
(2010) Quantitative 
reconstitution of 
mitotic CDK1 
activation in somatic 
cell extracts. Mol. 
Cell 37, 753–767.  
CyclinA –| 
CyclinB –| 
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Supplementary Table S3: Apoptosis Links 
Node Logic Gate Link Reference 
BAD NOT AKT AND NOT ERK 
ERK –| 
Pucci, B., Indelicato, 
M., Paradisi, V., 
Reali, V ., Pellegrini, 
L., Aventaggiato, M., 
Karpinich, N. O., Fini, 
M., Russo, M. A., 
Farber, J. L., and 
Tafani, M. (2009) 
ERK-1 MAP kinase 
prevents TNF-induced 
apoptosis through bad 
phosphorylation and 
inhibition of Bax 
translocation in HeLa 
Cells. J. Cell. 
Biochem. 108, 1166– 
1174.  
AKT–| 
Datta, S. R., Dudek, 
H., Tao, X., Masters, 
S., Fu, H., Gotoh, Y., 
and Greenberg, M. E. 
(1997) Akt 
phosphorylation of 
BAD couples survival 
signals to the cell- 
intrinsic death 
machinery. Cell 91, 
231–241.  									
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BAK 
(BID OR NOT 
BCL2) AND (BID 
OR NOT BCLXL) 
AND (NOT BCL2 
OR NOT BCLXL) 
BID →  
Sarosiek, K. A., Chi, 
X., Bachman, J. A., 
Sims, J. J., Montero, 
J., Patel, L., Flanagan, 
A., Andrews, D. W., 
Sorger, P., and Letai, 
A. (2013) BID 
preferentially activates 
BAK while BIM 
preferentially activates 
BAX, affecting 
chemotherapy 
response. Mol. Cell 
51, 751–765.  
BCLXL –| 
Willis, S. N., Chen, 
L., Dewson, G., Wei, 
A., Naik, E., Fletcher, 
J. I., Adams, J. M., 
and Huang, D. C. S. 
(2005) Proapoptotic 
Bak is sequestered by 
Mcl-1 and Bcl-xL, but 
not Bcl-2, until 
displaced by BH3-
only proteins. Genes 
Dev 19, 1294– 1305.  
BCL2 –| 
Dlugosz, P. J., Billen, 
L. P., Annis, M. G., 
Zhu, W., Zhang, Z., 
Lin, J., Leber, B., and 
Andrews, D. W. 
(2006) Bcl-2 changes 
conformation to 
inhibit Bax 
oligomerization. 
EMBO J 25, 2287– 
2296.  			
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BAX 
(BID OR BIM) 
AND (BID OR 
NOT BCL2) AND 
(BID OR NOT 
BCLXL) 
BID →  
Desagher, S., Osen-
Sand, A., Nichols, A., 
Eskes, R., Montessuit, 
S., Lauper, S., … 
Martinou, J.-C. 
(1999). Bid-induced 
Conformational 
Change of Bax Is 
Responsible for 
Mitochondrial 
Cytochrome c Release 
during Apoptosis. The 
Journal of Cell 
Biology, 144(5), 891–
901. 
BIM →  
Sarosiek, K. A., Chi, 
X., Bachman, J. A., 
Sims, J. J., Montero, 
J., Patel, L., Flanagan, 
A., Andrews, D. W., 
Sorger, P., and Letai, 
A. (2013) BID 
preferentially activates 
BAK while BIM 
preferentially activates 
BAX, affecting 
chemotherapy 
response. Mol. Cell 
51, 751–765.  
BCLXL –| 
Muñoz-Pinedo, C., 
Guío-Carrión, A., 
Goldstein, J. C., 
Fitzgerald, Newmeyer, 
D. D., and Green, D. 
R. (2006) Different 
mitochondrial 
intermembrane space 
proteins are released 
during apoptosis in a 
manner that is 
coordinately initiated 
but can vary in 
duration. PNAS 103, 
11573–11578.  
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BCL2–| 
Murphy, K. M., 
Ranganathan, V ., 
Farnsworth, M. L., 
Kavallaris, M., and 
Lock, R. B. (2000) 
Bcl-2 inhibits Bax 
translocation from 
cytosol to 
mitochondria during 
drug-induced 
apoptosis of human 
tumor cells. Cell 
Death Differ. 7, 102–
111.  
BCL2 NOT BAD AND 
NOT Casp3 
BAD –| 
Yang, E., Zha, J., 
Jockel, J., Boise, L. 
H., Thompson, C. B., 
and Korsmeyer, S. J. 
(1995) Bad, a 
heterodimeric partner 
for Bcl-xL and Bcl-2, 
displaces bax and 
promotes cell death. 
Cell 80, 285–291.  
Casp3–| 
Liang, Y., Nylander, 
K. D., Yan, C., and 
Schor, N. F. (2002) 
Role of caspase 3- 
dependent Bcl-2 
cleavage in 
potentiation of 
apoptosis by Bcl-2. 
Mol. Pharmacol. 61, 
142–149.  						
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BCLXL NOT BAD AND NOT Casp3 
BAD –| 
Yang, E., Zha, J., 
Jockel, J., Boise, L. 
H., Thompson, C. B., 
and Korsmeyer, S. J. 
(1995) Bad, a 
heterodimeric partner 
for Bcl-xL and Bcl-2, 
displaces bax and 
promotes cell death. 
Cell 80, 285–291. 
Casp3 –| 
Liang, Y., Nylander, 
K. D., Yan, C., and 
Schor, N. F. (2002) 
Role of caspase 3- 
dependent Bcl-2 
cleavage in 
potentiation of 
apoptosis by Bcl-2. 
Mol. Pharmacol. 61, 
142–149.  
BID 
(Casp8 OR NOT 
BCL2) AND 
(Casp8 OR NOT 
MCL-1) 
Casp8 → 
Li, H., Zhu, H., Xu, 
C., and Yuan, J. 
(1998) Cleavage of 
BID by Caspase 8 
Mediates the 
Mitochondrial 
Damage in the Fas 
Pathway of Apoptosis. 
Cell 94, 491–501.  
MCL-1 –| 
Clohessy, J. G., 
Zhuang, J., de Boer, 
J., Gil-Gómez, G., and 
Brady, H. J. M. (2006) 
Mcl-1 interacts with 
truncated Bid and 
inhibits its induction 
of cytochrome c 
release and its role in 
receptor- mediated 
apoptosis. J. Biol. 
Chem. 281, 5750–
5759.  
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BCL2 –| 
Yi, X., Yin, X.-M., 
and Dong, Z. (2003) 
Inhibition of Bid- 
induced Apoptosis by 
Bcl-2 tBid 
INSERTION, Bax 
TRANSLOCA TION, 
AND Bax/Bak 
OLIGOMERIZA 
TION SUPPRESSED. 
J. Biol. Chem. 278, 
16992–16999.  
BIM 
NOT BCL2 AND 
NOT BCLXL AND 
NOT CAD AND 
(GSK3 OR NOT 
MCL-1) 
GSK3 →  
Beurel, E., and Jope, 
R. S. (2006) The 
Paradoxical Pro- and 
Anti-apoptotic 
Actions of GSK3 in 
the Intrinsic and 
Extrinsic Apoptosis 
Signaling Pathways. 
Prog Neurobiol 79, 
173– 189.  
MCL-1 –| 
Hagenbuchner, J., 
Kiechl-Kohlendorfer, 
U., Obexer, P., and 
Ausserlechner, M. J. 
(2013) A novel Mcl1 
variant inhibits 
apoptosis via 
increased Bim 
sequestration. 
Oncotarget 4, 1241– 
1252.  
CAD–| 
Kalimuthu, S., and Se- 
Kwon, K. (2013) Cell 
Survival and 
Apoptosis Signaling 
as Therapeutic Target 
for Cancer: Marine 
Bioactive Compounds. 
Int J Mol Sci 14, 
2334–2354.  
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BCLXL–| 
Mérino, D., Khaw, S. 
L., Glaser, S. P., 
Anderson, D. J., 
Belmont, L. D., 
Wong, C., Yue, P., 
Robati, M., Phipson, 
B., Fairlie, W. D., 
Lee, E. F., Campbell, 
K. J., Vandenberg, C. 
J., Cory, S., Roberts, 
A. W., Ludlam, M. J. 
C., Huang, D. C. S., 
and Bouillet, P. (2012) 
Bcl-2, Bcl-xL, and 
Bcl-w are not 
equivalent targets of 
ABT-737 and 
navitoclax (ABT-263) 
in lymphoid and 
leukemic cells. Blood 
119, 5807–5816.  
BCL2–| 
CAD Casp3 AND Casp9 
Casp3 →  
Yi, X., Yin, X.-M., 
and Dong, Z. (2003) 
Inhibition of Bid- 
induced Apoptosis by 
Bcl-2 tBid 
INSERTION, Bax 
TRANSLOCA TION, 
AND Bax/Bak 
OLIGOMERIZA 
TION SUPPRESSED. 
J. Biol. Chem. 278, 
16992–16999.  
Casp9 →  
Guerrero, A. D., 
Schmitz, I., Chen, M., 
and Wang, J. (2012) 
Promotion of Caspase 
Activation by 
Caspase- 9-mediated 
Feedback 
Amplification of 
Mitochondrial 
Damage. J Clin Cell 
Immunol 3.  
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Casp3 
(Casp3 OR Casp8 
OR Casp9) AND 
(Casp3 OR Casp8 
OR NOT IAPs) 
AND (Casp3 OR 
Casp9 OR NOT 
IAPs) AND (Casp8 
OR Casp9 OR 
NOT IAPs) 
IAPs –| 
Deveraux, Q. L., 
Takahashi, R., 
Salvesen, G. S., and 
Reed, J. C. (1997) X- 
linked IAP is a direct 
inhibitor of cell-death 
proteases. Nature 388, 
300–304.  
Casp8 → 
Stennicke, H. R., 
Jürgensmeier, J. M., 
Shin, H., Deveraux, 
Q., Wolf, B. B., Yang, 
X., Zhou, Q., Ellerby, 
H. M., Ellerby, L. M., 
Bredesen, D., Green, 
D. R., Reed, J. C., 
Froelich, C. J., and 
Salvesen, G. S. (1998) 
Pro-caspase-3 is a 
major physiologic 
target of caspase-8. J. 
Biol. Chem. 273, 
27084–27090.  
Casp9 → 
Fuentes-Prior, P., and 
Salvesen, G. S. (2004) 
The protein structures 
that shape caspase 
activity, specificity, 
activation and 
inhibition. Biochem. J. 
384, 201–232.  
Casp3 → N/A 							
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Casp8 Casp3 Casp3 → 
Ferreira, K. S., Kreutz, 
C., Macnelly, S., 
Neubert, K., Haber, 
A., Bogyo, M., 
Timmer, J., and 
Borner, C. (2012) 
Caspase-3 feeds back 
on caspase-8, Bid and 
XIAP in type I Fas 
signaling in primary 
mouse hepatocytes. 
Apoptosis 17, 503– 
515.  
Casp9 
(Casp3 OR 
Cyto_C) AND 
(Casp3 OR NOT 
IAPs) 
IAPs –| 
Deveraux, Q. L., 
Takahashi, R., 
Salvesen, G. S., and 
Reed, J. C. (1997) X- 
linked IAP is a direct 
inhibitor of cell-death 
proteases. Nature 388, 
300–304.  
Cyto_C → 
Jiang, X., and Wang, 
X. (2000) Cytochrome 
c Promotes Caspase-9 
Activation by 
Inducing Nucleotide 
Binding to Apaf-1. J. 
Biol. Chem. 275, 
31199–31203.  
Casp3 → N/A  
Cyto_C BAK OR BAX BAK → 
Renault, T. T., Floros, 
K. V., and Chipuk, J. 
E. (2013) BAK/BAX 
activation and 
cytochrome c release 
assays using isolated 
mitochondria. 
Methods 61, 146–155.  
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BAX → 
Renault, T. T., Floros, 
K. V., and Chipuk, J. 
E. (2013) BAK/BAX 
activation and 
cytochrome c release 
assays using isolated 
mitochondria. 
Methods 61, 146–155.  
IAPs NOT SMAC SMAC –| 
Vucic, D., Deshayes, 
K., Ackerly, H., 
Pisabarro, M. T., 
Kadkhodayan, S., 
Fairbrother, W. J., and 
Dixit, V . M. (2002) 
SMAC Negatively 
Regulates the Anti- 
apoptotic Activity of 
Melanoma Inhibitor of 
Apoptosis (ML-IAP). 
J. Biol. Chem. 277, 
12275–12279.  
MCL-1 
NOT Casp3 AND 
(ERK OR NOT 
E2F1) 
Casp3 –| 
Willis, S. N., Chen, 
L., Dewson, G., Wei, 
A., Naik, E., Fletcher, 
J. I., … Huang, D. C. 
S. (2005). 
Proapoptotic Bak is 
sequestered by Mcl-1 
and Bcl-xL, but not 
Bcl-2, until displaced 
by BH3-only proteins. 
Genes & 
Development, 19(11), 
1294–1305.  
E2F1–| 
Croxton, R., Ma, Y., 
Song, L., Haura, E. B., 
and Cress, W. D. 
(2002) Direct 
repression of the Mcl- 
1 promoter by E2F1. 
Oncogene 21, 1359– 
1369.  
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ERK → 
Ding, Q., Huo, L., 
Yang, J.-Y., Xia, W., 
Wei, Y., Liao, Y., 
Chang, C.-J., Y ang, 
Y., Lai, C.-C., Lee, 
D.- F., Yen, C.-J., 
Chen, Y .-J. R., Hsu, 
J.-M., Kuo, H.-P., Lin, 
C.-Y., Tsai, F.-J., Li, 
L.-Y., Tsai, C.-H., and 
Hung, M.-C. (2008) 
Down- regulation of 
myeloid cell 
leukemia-1 through 
inhibiting Erk/Pin 1 
pathway by sorafenib 
facilitates 
chemosensitization in 
breast cancer. Cancer 
Res. 68, 6109–6117.  
SMAC BAK OR BAX 
BAK → 
Arnoult, D., Gaume, 
B., Karbowski, M., 
Sharpe, J. C., Cecconi, 
F., and Youle, R. J. 
(2003) Mitochondrial 
release of AIF and 
EndoG requires 
caspase activation 
downstream of 
Bax/Bak-mediated 
permeabilization. 
EMBO J 22, 4385– 
4399.  
BAX → 
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Supplementary Table S4. Bone Morphogenetic Protein Links 
Node Logic Gate Link Reference 
BMP BMP BMP → N/A 
SMAD BMP BMP → 
Ueberham, U., & Arendt, 
T. (2013). The Role of 
Smad Proteins for 
Development, 
Differentiation and 
Dedifferentiation of 
Neurons.  
Zic1_3 (ERK OR Zic1_3) AND (NOT SMAD 
OR Zic1_3) 
SMAD –| 
Aruga, J., & Mikoshiba, K. 
(2011). Role of BMP, FGF, 
calcium signaling, and Zic 
proteins in vertebrate 
neuroectodermal 
differentiation. 
Neurochemical Research, 
36(7), 1286–1292.  
ERK → 
Marchal, L., Luxardi, G., 
Thomé, V., & 
Kodjabachian, L. (2009). 
BMP inhibition initiates 
neural induction via FGF 
signaling and Zic genes. 
Proceedings of the 
National Academy of 
Sciences, 106(41), 17437–
17442.  
Zic1_3 → N/A 
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Supplementary Table S5. Leukemia Inhibitory Factor Links 
Node Logic Gate Link Reference 
LIF LIF LIF →  N/A 
LIFR LIF LIF → 
Cheng, J.-G., Chen, 
J. R., Hernandez, L., 
Alvord, W. G., & 
Stewart, C. L. 
(2001). Dual control 
of LIF expression 
and LIF receptor 
function regulate 
Stat3 activation at 
the onset of uterine 
receptivity and 
embryo 
implantation. 
Proceedings of the 
National Academy 
of Sciences, 98(15), 
8680–8685.  
Stat3 LIFR LIFR → 
Niwa, H., Ogawa, 
K., Shimosato, D., 
& Adachi, K. 
(2009). A parallel 
circuit of LIF 
signalling pathways 
maintains 
pluripotency of 
mouse ES cells. 
Nature, 460(7251), 
118–122.  
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Supplementary Table S6. Pluripotency Links 
Node Logic Gate Link Reference 
B_Catenin NOT GSK3 GSK3 –| 
Metcalfe, C., & 
Bienz, M. (2011). 
Inhibition of GSK3 
by Wnt signalling--
two contrasting 
models. Journal of 
Cell Science, 124(Pt 
21), 3537–3544.  
Esrrb Nanog AND NOT TCF3 
TCF3 –| 
Martello, G., 
Sugimoto, T., 
Diamanti, E., Joshi, 
A., Hannah, R., 
Ohtsuka, S., … 
Smith, A. (2012). 
Esrrb Is a Pivotal 
Target of the 
Gsk3/Tcf3 Axis 
Regulating 
Embryonic Stem 
Cell Self-Renewal. 
Cell Stem Cell, 
11(4), 491–504.  
Nanog –| 
Festuccia, N., 
Osorno, R., 
Halbritter, F., 
Karwacki-Neisius, 
V., Navarro, P., 
Colby, D., … 
Chambers, I. (2012). 
Esrrb Is a Direct 
Nanog Target Gene 
that Can Substitute 
for Nanog Function 
in Pluripotent Cells. 
Cell Stem Cell, 
11(4), 477–490.  					
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Klf4 NOT ERK AND Stat3 
ERK –| 
Kim, M. O., Kim, 
S.-H., Cho, Y.-Y., 
Nadas, J., Jeong, C.-
H., Yao, K., … 
Dong, Z. (2012). 
ERK1 and ERK2 
regulate embryonic 
stem cell self-
renewal through 
phosphorylation of 
Klf4. Nature 
Structural & 
Molecular Biology, 
19(3), 283–290.  
Stat3 → 
Qin, S., & Zhang, 
C.-L. (2012). Role 
of Krüppel-Like 
Factor 4 in 
Neurogenesis and 
Radial Neuronal 
Migration in the 
Developing 
Cerebral Cortex. 
Molecular and 
Cellular Biology, 
32(21), 4297–4305. 
Nanog 
(Esrrb OR 
Oct4_Sox2) AND 
(Esrrb OR Tbx3) 
AND (Oct4_Sox2 
OR Tbx3) 
Tbx3 → 
Russell, R., Ilg, M., 
Lin, Q., Wu, G., 
Lechel, A., 
Bergmann, W., … 
Kleger, A. (2015). 
A Dynamic Role of 
TBX3 in the 
Pluripotency 
Circuitry. Stem Cell 
Reports, 5(6), 1155–
1170.  									
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Esrrb → 
Festuccia, N., 
Osorno, R., 
Halbritter, F., 
Karwacki-Neisius, 
V., Navarro, P., 
Colby, D., … 
Chambers, I. (2012). 
Esrrb Is a Direct 
Nanog Target Gene 
that Can Substitute 
for Nanog Function 
in Pluripotent Cells. 
Cell Stem Cell, 
11(4), 477–490. 
Oct4_Sox2 →  
Pan, G., & 
Thomson, J. A. 
(2007). Nanog and 
transcriptional 
networks in 
embryonic stem cell 
pluripotency. Cell 
Research, 17(1), 
42–49.  
Oct4_Sox2 Oct4 AND Sox2 
Oct4 →  
Chew, J.-L., Loh, 
Y.-H., Zhang, W., 
Chen, X., Tam, W.-
L., Yeap, L.-S., … 
Ng, H.-H. (2005). 
Reciprocal 
Transcriptional 
Regulation of 
Pou5f1 and Sox2 
via the Oct4/Sox2 
Complex in 
Embryonic Stem 
Cells. Molecular 
and Cellular 
Biology, 25(14), 
6031–6046.  
Sox2 →  
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Oct4 
(Esrrb OR Klf4 OR 
Oct4_Sox2) AND 
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